BR112013027848B1 - COMPOSITION, PROCESS FOR THE PROTECTION OF AN ORGANIC MATERIAL, COMPOUND, AND USE OF A COMPOUND - Google Patents

Abstract

composition, process for the protection of an organic material, compound, and, use of a compound a composition, which comprises a) an organic material susceptible to oxidative, thermal or light degradation and b) a compound of the formula i where r1, r2 , r3, r4, r5, r6, r7, r8, r9 and r10 are, independently of one another h, h, c1-c8 alkyl, c4-c8 cycloalkyl, phenyl, c1-c4 alkoxy or halogen; n is 1, 2, 3 or 4 and when n is 1 a is -c (= o) -or'1, -c (= o) -n (r'2) (r'3), -cn, phenyl , which is unsubstituted or substituted by one or more c1-c8 alkyl, c1-c4 alkoxy, c5-c 7 cycloalkyl or halogen, -h or -so2-phenyl; when n is 2 a is -c (= o) -o-z1-oc (= o) -, -c (= o) -n (r''1) -z2-n (r''2) -c (= o) - or piperazine-n, n'-biscarbonyl.

Description

description

[01] Organic materials are susceptible to degradation, which can be induced by heat, light and / or oxidation. To reduce such degradation, numerous solutions regarding the incorporation or addition of a stabilizer are proposed.

[02] There is still a need for additional technical solutions regarding the stabilization of organic material against the harmful impact of heat, light and / or oxidation.

[03] US-A-2003/0083405 describes, inter alia, 5H-dihydro-furan-2-one derivatives as antioxidants for the stabilization of a polymer.

[04] It has now been observed that a specific group of 5H-dihydro-furan-2-one derivatives are suitable for the stabilization of organic material against degradation by light heat and / or oxidation.

em que quando n é 1 A é -C(=O)-OR’i, -C(=O)-N(R’2)(R’3), -CN, fenila, que é não substituído ou substituído por um ou mais alquila Ci-Cs, alcóxi C1-C4, cicloalquila C5-C7 ou halogênio, -H ou -SO2-fenila; quando n é 2 A é -C(=O)-O-Zi-O-C(=O)-, -C(=O)-N(R”i)-Z2-N(R”2)- C(=O)- ou piperazino-N,N’-biscarbonila; quando n é 3 A é alcano Cs-Ci2 tri-(oxicarbonila), 3-etil-3-azapentano- l,5,2’-tri-(oxicarbonila), l,4,7-triazaeptano-l,4,7-tricarbonila, 1,4,8- triazaoctano-1,4,8-tricarbonila ou 1,5,9-triazanonano-l ,5,9-tricarbonila; quando n é 4 A é alcano C4-C16 tetra-(oxicarbonila), 1,4,7,10- tetraazadecano-l,4,7,10-tetracarbonila, 1,4,8,1 l-tetraazaundecano-1,4,8,11- tetracarbonila ou 1,5,8,12-tetraazadodecano-1,5,8,12-tetracarbonila; n é 1, 2, 3 ou 4; Ri, R2, R3, R4, R5, RÓ, R7, Rs, R9 e Rio são independentemente um do outro H, alquila Ci-Cs, cicloalquila C4-C8, fenila, alcóxi C1-C4 ou halogênio; R’i é H, alquila C1-C22, alquenila C2-C18, alcino-ila C3-Ci2, cicloalquila C4-C8, que é não substituído ou substituído por um a três alquila C1-C4, cicloalquila C4-C8-alquila C1-C4, alquila C5-C20 bicíclica ou tricíclica, arila C6-Ci4-alquila C1-C4, alquila C2-C12, que é substituído por um ou mais grupos hidroxila, alquila C4-C12, que é interrompido por um ou mais átomos de oxigênio, alquila C4-C18, que é interrompido por um átomo de enxofre, 2,2,6,6-tetrametilpiperidino-4-ila, 1-(alquila Ci -Cs)-2,2,6,6- tetrametilpiperidino-4-ila ou 1-(alcóxi Ci-Ci8)-2,2,6,6-tetrametilpiperidino-4- ila; R’2 e R’3 são independentemente um do outro H, alquila Ci- C22, alquenila C2-Ci8, cicloalquila C4-C8, que é não substituído ou substituído por um a três alquila C1-C4, cicloalquila C4-C8-alquila C1-C4, arila C6-Ci4- alquila C1-C4, alquila C2-C6, que é substituído por um grupo hidroxila, arila CÓ-CIO, 2,2,6,6-tetrametilpiperidino-4-ila, 1-(alquila CI-C8)-2,2,6,6- tetrametilpiperidino-4-ila ou l-(alcóxi Ci-Ci8)-2,2,6,6-tetrametilpiperidino-4- ila ou R’2 e R’3 forma, junto com o átomo de hidrogênio ao qual estes são ligados ao heterociclo saturado de 5, 6 ou 7 membros; R”i e R”2 são independentemente um do outro H, alquila Ci- C22, alquenila C2-C18, cicloalquila C4-C8, que é não substituído ou substituído por um a três alquila C1-C4, cicloalquila C4-C8-alquila C1-C4, arila CÔ-CU- alquila C1-C4; Zi é alquileno C2-C12, cicloalquileno C4-C8, cicloalcano C4-C8- bis-(alquileno C1-C4), areno CÓ-CU bis-(alquileno C1-C4), alquileno C3-C6, que é substituído por um ou mais grupos hidroxila, alquileno C4-C12, que é interrompido por um ou mais átomos de oxigênio, hexaidro-furo[3,2- b]furano-3,6-diila, alquileno C4-C8, que é interrompido por um átomo de enxofre, 3-(alquila Ci-C8)-3-azapentano-l,5-diila, 4-(alquila CI-C8)-4- azaeptano-l,7-diila ou l-etil-2,2,6,6-tetrametilpiperidino-4,2’-diila e Z2 é alquileno C2-C12, cicloalquileno C4-C8, arileno CÓ-CR, cicloalcano C4-C8-bis(alquileno C1-C4), areno CÓ-CR bis-(alquileno C1-C4), alquileno C4-C12, que é interrompido por um ou mais átomos de oxigênio, 3- (alquila Ci-C8)-3-azapentano-l,5-diila ou 4-(alquila Ci-C8)-4-azaeptano-l,7- diila.[05] The present invention relates to a composition, which comprises a) an organic material susceptible to thermal degradation or induced by oxidative light and b) a compound of formula I

where when n is 1 A is -C (= O) -OR'i, -C (= O) -N (R'2) (R'3), -CN, phenyl, which is unsubstituted or substituted by one or more C 1 -C 6 alkyl, C 1 -C 4 alkoxy, C 5-C 7 cycloalkyl or halogen, -H or -SO 2 -phenyl; when n is 2 A is -C (= O) -O-Zi-OC (= O) -, -C (= O) -N (R ”i) -Z2-N (R” 2) - C (= O) - or piperazine-N, N'-biscarbonyl; when n is 3 A it is Cs-C12 alkane tri- (oxycarbonyl), 3-ethyl-3-azapentan-1, 5,2'-tri- (oxycarbonyl), 1, 4,7-triazaeptane-1, 4,7 -tricarbonyl, 1,4,8-triazaoctane-1,4,8-tricarbonyl or 1,5,9-triazanonane-1,5,9-tricarbonyl; when n is 4 A is C4-C16 alkane tetra- (oxycarbonyl), 1,4,7,10-tetraazadecane-1, 4,7,10-tetracarbonyl, 1,4,8,1 l-tetraazaundecane-1,4 , 8,11- tetracarbonyl or 1,5,8,12-tetraazadodecane-1,5,8,12-tetracarbonyl; n is 1, 2, 3 or 4; Ri, R2, R3, R4, R5, RÓ, R7, Rs, R9 and Rio are independently of each other H, C1-Cs alkyl, C4-C8 cycloalkyl, phenyl, C1-C4 alkoxy or halogen; R'i is H, C1-C22 alkyl, C2-C18 alkenyl, C3-C2 alkynyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-C1 cycloalkyl -C4, bicyclic or tricyclic C5-C20 alkyl, C6-C14 alkyl C1-C4 alkyl, C2-C12 alkyl, which is replaced by one or more hydroxyl groups, C4-C12 alkyl, which is interrupted by one or more carbon atoms oxygen, C4-C18 alkyl, which is interrupted by a sulfur atom, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (C1 -Cs alkyl) -2,2,6,6- tetramethylpiperidine-4 -yl or 1- (C 1-8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C1-C22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-alkyl cycloalkyl C1-C4, C6-C14 aryl-C1-C4 alkyl, C2-C6 alkyl, which is replaced by a hydroxyl group, COC-CIO aryl, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (alkyl CI-C8) -2,2,6,6- tetramethylpiperidine-4-yl or l- (C1-8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 form , together with the hydrogen atom to which they are attached to the 5, 6 or 7-membered saturated heterocycle; R ”i and R” 2 are independently of each other H, C-C22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-C1 cycloalkyl -C4, CÔ-CU-aryl-C1-C4 alkyl; Zi is C2-C12 alkylene, C4-C8 cycloalkylene, C4-C8-bis- (C1-C4 alkylene) cycloalkane, CÓ-CU bis- (C1-C4 alkylene) arene, C3-C6 alkylene, which is replaced by one or more hydroxyl groups, C4-C12 alkylene, which is interrupted by one or more oxygen atoms, hexahydro-bore [3,2- b] furan-3,6-diyl, C4-C8 alkylene, which is interrupted by an atom of sulfur, 3- (C 1 -C 8 alkyl) -3-azapentane-1,5-diyl, 4- (C 1 -C 8 alkyl) -4-azaeptane-1,7-diyl or 1-ethyl-2,2,6, 6-tetramethylpiperidine-4,2'-diyl and Z2 is C2-C12 alkylene, C4-C8 cycloalkylene, CÓ-CR arylene, C4-C8-bis cycloalkane (C1-C4 alkylene), CÓ-CR bis- (C1 alkylene arylene) -C4), C4-C12 alkylene, which is interrupted by one or more oxygen atoms, 3- (C1-C8 alkyl) -3-azapentane-1,5-diyl or 4- (C1-C8 alkyl) -4- azaeptane-1,7-diyl.

[06] A compound of formula I has at least one asymmetric carbon atom, that is, the carbon atom at position 5 of the furan-2-one ring, which results in enantiomers. The invention relates to any of these enantiomers or mixtures thereof. Various combinations of substituents in formula I lead to the presence of at least two asymmetric carbon atoms, which results in diastereomers. The invention relates to any of these diastereomers or mixtures thereof.

[07] C1-C22 alkyl is straight or branched and, for example, methyl, ethyl, n-propyl, 1-methyl-ethyl, n-butyl, 1-methyl-propyl, 2-methyl-propyl, 1,1- dimethyl-ethyl, n-pentyl, 1-methyl-butyl, 3-methyl-butyl, n-hexyl, 1-methyl-pentyl, 2-methyl-pentyl, 4-methyl-pentyl, 2-ethyl-butyl, n- heptyl, 1-methylhexyl, n-octyl, 1-methylheptyl, 2-ethylhexyl, 5,5-dimethylhexyl, 1,1,3,3-tetramethyl-butyl, n-nonyl, 2- ethylheptyl, n-decyl, undecyl, n-dodecyl, tridecyl, tetradecyl, pentadecyl, n-hexadecyl or n-octadecyl. C-C18 alkyl is preferred, in particular C1-C12 alkyl, especially C-Cs alkyl, most especially C-Cz-alkyl

[08] C2-C18 alkenyl is linear or branched and, for example, vinyl, allyl, Z- or E-but-2-eneyl, Z- or E-but-3-eneyl, Z- or E -pent-2-ene-yl, pent-4-ene-yl, Z- or E-2-methyl-but-2-ene-yl, Z- or E-3-methyl-but-3-ene-yl , Z- or E-hex-1-eneyl, Z- or E-hexadec-9-eneyl or Z- or E-octadec-9-eneyl.

[09] C3-C12 alkynyl is, for example, propargyl, but-2-ynyl or undec-11-ynyl.

[10] C4-C8 cycloalkyl is, for example, cyclobutyl, cyclopentyl, cyclohexyl, cycloeptyl or cyclooctyl. C5-C7 cycloalkyl, in particular cyclohexyl, is preferred.

[11] C4-C8 cycloalkyl, which is replaced by one to three C1-4 alkyl, is, for example, 3,4-dimethyl-cyclopentyl, 4-methyl-cyclohexyl, 2-methyl-cyclohexyl, 3,5-dimethyl -cyclohexyl or 4- (1-methyl-ethyl) -cyclohexyl or 5-methyl-2- (1-methyl-ethyl) -cyclohexyl.

[12] COC-CIO aryl is, for example, phenyl, 2-methyl-phenyl, 3-methyl-phenyl, 4-methyl-phenyl, 2,4-dimethyl-phenyl, 4- (1,1-dimethylethyl) - phenyl, biphenyl-4-yl, naphthalen-1-yl or naphthalen-2-yl. Phenyl is preferred.

[13] bicyclic or tricyclic C5-C20 alkyl is, for example, 2-methyl-bicyclo [2.2.1] heptane-l'-yl, 1,7,7-trimethylbicyclo [2.2.1] heptane-2-yl, adamantane-yl, 1-methyl-adamantane-l'-yl or 1,3-dimethyl-adamantane-l'-yl.

[14] C4-C8-C1-C4-cycloalkyl is, for example, 2- (cyclopentyl) -ethyl, cyclohexyl-methyl, 2- (cyclohexyl) -ethyl, 2- (cyclohexyl) -l-methyl-ethyl or ( cycloeptyl) -methyl.

[15] C1-C4-C4-C4-aryl is, for example, benzyl, 4-methyl-benzyl, 2-phenyl-etha, 3,5-dimethyl-benzyl, 1-phenyl-1, 1-dimethyl-methyl, 3 -phenyl-propyl, 3-phenyl-2-methyl-propyl, 3,5-di-tert-butyl-benzyl or biphenyl-4-yl-methyl.

[16] C2-C12 alkyl, which is substituted by one or more hydroxyl groups, is, for example, 2-hydroxy-ethyl, 3-hydroxy-propyl, 2-hydroxy-2-methyl-ethyl, 2,2-dimethyl -3-hydroxy-propyl, 4-hydroxy-butyl, 6-hydroxy-hexyl, 2,3-dihydroxy-propyl, 2-hydroxy-butyl, 2-hydroxy-hexyl, 1,3-dihydroxy-propane-2-yl , 2,3,4,5-tetrahydroxy-pentyl or 2,3,4,5,6-pentahydroxy-hexyl. C2-C8 alkyl is preferred, which is replaced by a hydroxyl group. In particular, 2-hydroxy-ethyl or 2-hydroxy-2-methyl-ethyl is preferred.

[17] Ci-Cis alkoxy is, for example, methoxy, ethoxy, n-propoxy, 1-methyl-ethoxy, n-butoxy, 1-methyl-propoxy, 2-methyl-propoxy, 1,1-dimethyl-ethoxy, n-pentoxy, 1-methyl-butoxy, 2-methyl-butoxy, 3-methyl-butoxy, n-hexane-oxy, n-heptane-oxy, n-octane-oxy or 1-methyl-heptane-oxy. C1-C4 alkoxy is preferred.

[18] Phenyl, which is unsubstituted or substituted by one or more C1 -Cs alkyl, C1-C4 alkoxy, C5-C7 cycloalkyl or halogen, is, for example, phenyl, 2-methyl-phenyl, 3-methyl-phenyl , 3,5-dimethyl-phenyl, 4-methyl-phenyl, 3- (1-methyl-propyl) -phenyl, 4- (1-methyl-propyl) -phenyl, 4- (1,1-dimethyl-ethyl) -phenyl, 4- (1,1,3,3-tetramethyl-butyl) -phenyl, 4-cyclohexyl-phenyl, biphenyl-4-yl, 2-methoxy-phenyl, 3-methoxy-phenyl, 4-methoxy-phenyl , 4-ethoxy-phenyl, 2-chloro-phenyl, 3-chloro-phenyl, 4-chloro-phenyl or 4-bromo-phenyl. Phenyl, which is unsubstituted or substituted by C 1 -C 6 alkyl, C 1 -C 4 alkoxy, C 5 -C 7 cycloalkyl or halogen, is preferred. Phenyl, which is unsubstituted, is preferred.

[19] C4-C12 alkyl, which is interrupted by one or more oxygen atoms, is, for example, 2-ethoxy-ethyl, 2- (2-methoxy-ethoxy) -ethyl, 2-n-butoxy-ethyl, 2- [2- (2-methoxy-ethoxy) -ethoxy] -ethyl, 2- [2- [2- (2-methoxy-ethoxy) -ethoxy] -ethoxy] -ethyl, 2- (2-methoxy-l -methyl-ethoxy) -1-methyl-ethyl, 3- (n-propoxy) -propyl, 2- (2-hydroxy-ethoxy) -ethyl, 2- [2- [2- (2-hydroxy-ethoxy) - ethoxy] -ethoxy] -ethyl or 2- [2- (2- hydroxy-2-methyl-ethoxy) -2-methyl-ethoxy] -2-methyl-ethyl.

[20] C4-C16 alkyl, which is interrupted by a sulfur atom, is, for example, 3-thiaundecyl or 3-thiapentadecyl.

[21] Halogen is, for example, a chlorine atom, a bromine atom or an iodine atom. A chlorine atom is preferred.

[22] C2-C12 alkylene is, for example, ethylene, 1-methyl-ethane-1,2-diyl, n-propylene, n-butylene, 2-methyl-butane-1,4-diyl, hexamethylene or decane- 1.10-diyl.

[23] C4-C8 cycloalkylene is, for example, cyclopentane-1,2-diyl, cyclopentane-1,3-diyl, cyclohexane-1,4-diyl, cyclohexane-1,2-diyl, cyclooctane-1,2- diyl or cycloeptane-1,3-diyl.

[24] arylene CÓ-CU is, for example, 1,3-phenylene, 1,4-phenylene, 2,3-dimethyl-benzene-1,4-diyl, biphenyl-4,4'-diyl, naphtalene-2 , 6-diyl or naphthalene-1,4-diyl.

[25] C4-C8-bis- (C1-C4 alkylene) cycloalkane is, for example, cyclopentane-1,3-bismethylene, cyclohexane-1,4-bismethylene, cyclohexane-1,3-bismethylene, cyclohexane-1,4 -bisethylene or cyclohexane-1,4-bis (1-methyl-ethane-1,2-diyl).

[26] arene CÓ-CU bis- (C1-C4 alkylene) is, for example, benzene- 26.1-ismethylene, benzene-1,4-bismethylene, naphthalene-1,4-bismethylene, naphthalene-2,6-bismetylene, 5-methyl-benzene-1,3-bismethylene, 5-tert-butyl-benzene-1,3-bismetylene, benzene-1,4-bisethylene, benzene-1,4-bis- (1-methyl-ethan-1 , 2-diyl) or biphenyl-4,4'-bismethylene.

[27] C3-C6 alkylene, which is substituted by one or more hydroxyl groups, is, for example, 2-hydroxy-propane-1,3-diyl, 1-hydroxymethyl-ethane-1,2-diyl, 2,3 , 4-trihydroxypentane-1,5-diyl, 2,3,4-trihydroxyexane-1,6-diyl or 2,3,4,5-tetrahydroxy-hexane-1,6-diyl.

[28] C4-C12 alkylene, which is interrupted by one or more oxygen atoms, is, for example, 2-ethoxyethane-1,2'-diyl, - (CH2CH2-O) 2-CH2CH2-, - (CH2CH2- O) 3-CH2CH2-, -CH (CH3) CH2-O-CH (CH3) CH2-, - [CH (CH3) CH2- O] 2-CH (CH3) CH2-, -CH2CH2CH2CH2-O-CH2CH2CH2CH2- or (CH2CH2CH2CH2-O) 2-CH2CH2CH2CH2-.

[29] C4-C8 alkylene, which is interrupted by a sulfur atom, is, for example, -CH2CH2-S-CH2CH2-, -CH2CH2CH2-S-CH2CH2CH2- or - CH (CH3) CH2-S-CH2-CH (CH3) -.

[30] 3- (C 1 -C 8 alkyl) -3-azapentane-1,5-diyl is, for example, - CH2CH2-N (CH3) -CH2CH2- OR -CH2CH2-N (CH2-C (CH3) 2- CH2-CH3) - CH2CH2-.

[31] 4- (C 1 -C 8 alkyl) -4-azaeptane-1,7-diyl is, for example, - CH2CH2CH2-N (CH3) -CH2CH2CH2- OR -CH2CH2-N (CH2-C (CH3) 2- CH2-CH3) - CH2CH2CH2-.

[32] a 5, 6 or 7 membered saturated heterocycle is, for example, pyrrolidine, piperidine, azepane, morpholine or 2,6-dimethyl-morpholine.

[33] The 'star' sign (= - *) indicates the free-binding valence of the carbon atom in the radicals described below.

[34] Hexahydro-furo [3,2-b] furan-3,6-diyl is a divalent radical:

[35] Piperazine-N, N'-biscarbonyl is a divalent radical:

[36] l-Ethyl-2,2,6,6-tetramethylpiperidine-4,2'-diyl is a bivalent radical:

2-metil-propano-l,2,3-tri-(oxicarbonila) como descrito:

2-metil-butano-l,2,r-tri-(oxicarbonila) como descrito:

2,2-dimetil-butano-l,r,l”-tri-(oxicarbonila) como descrito:

2,2-dimetil-pentano-l,r,l”-tri-(oxicarbonila) como descrito:

[37] C3-C12 tri- (oxycarbonyl) alkane is a trivalent radical and, for example propane-1,2,3-tri- (oxycarbonyl) as described:

2-methyl-propane-1,2,3-tri- (oxycarbonyl) as described:

2-methyl-butane-1,2, r-tri- (oxycarbonyl) as described:

2,2-dimethyl-butane-l, r, l ”-tri- (oxycarbonyl) as described:

2,2-dimethyl-pentane-l, r, l ”-tri- (oxycarbonyl) as described:

[38] 3-Ethyl-3-azapentan-1,5,2'-tri- (oxycarbonyl) is a trivalent radical as described:

[39] 1,4,7-Triazaeptane-1,4,7-tricarbonyl is a trivalent radical as described:

[40] 1,4,8-Triazaoctane-1,4,8-tricarbonyl is a trivalent radical as described:

[41] 1,5,9-Triazanonane-1,5,9-tricarbonyl is a trivalent radical as described:

butano-l,2,3,4-tetra-(oxicarbonila) como descrito:

hexano-l,3,4,6-tetra-(oxicarbonila) como descrito:

ou octano-l,3,6,8-tetra-(oxicarbonila) como descrito:

[42] C4-C16 alkane tetra- (oxycarbonyl) is a tetravalent radical and, for example, 2,2-dimethyl-propane-1,3,1 ', 1''-tetra- (oxycarbonyl) as described:

butane-1,2,3,4-tetra- (oxycarbonyl) as described:

hexane-1,3,4,6-tetra- (oxycarbonyl) as described:

or octane-1,3,6,8-tetra- (oxycarbonyl) as described:

[43] 1,4,7,10-Tetraazadecan-1, 4,7,10-tetracarbonyl is a tetravalent radical as described:

[44] 1,4,8,1 l-Tetraazaundecane-1,4,8 H-tetracarbonyl is a tetravalent radical as described:

[45] 1, 5,8,12-Tetraazadodecane-1, 5,8,12-tetracarbonyl is a tetravalent radical as described:

[46] A compound of formula I is preferred, where Ri, R2, R3, R4, R5, RÓ, R7, Rs, R9 and Rio are independently of each other H, C 1 -C 6 alkyl, C 4 -C 8 cycloalkyl, phenyl , C1-C4 alkoxy or halogen, with the proviso that at least Ri or R5 is H and at least RÓ or Rio is H.

[47] A compound of formula I is preferred, wherein Ri, R2, R3, R4 and Rs are independently of each other H, C1-C8 alkyl, C4-C8 cycloalkyl, phenyl, C1-C4 alkoxy or halogen;

[48] RÓ is Ri; R7 is R2; Rs is R3; R9 is R4 and Rio is Rs- A compound of formula I is preferred, where Ri, R2, R3, R4 and Rs are independently of each other H, C1-C8 alkyl, C4-C8 cycloalkyl, phenyl, C1-C4 alkoxy or halogen, with the proviso that at least Ri is H;

[49] RÓ is Rq R7 is R2; Rs is R3; Rç is R4 and Rio is Rs- A compound of formula I is preferred, wherein Ri, R2, R3, R4, Rs, RÓ, R7, Rs, R9 and Rio are independently of each other H, methyl or methoxy.

[50] A compound of formula I is preferred, where Ri, R2, R4, Rs, Re, R7, R9 and Rio are H and R3 and R8 are independently of each other H, C1-C8 alkyl, C4-C8 cycloalkyl , phenyl, C1-C4 alkoxy or halogen.

[51] A compound of formula I is preferred, where Ri, R2, R4, Rs, RÓ, R7, R9 and Rio are H and R3 and R8 are independently of each other H, C 1 -C 8 alkyl, phenyl or C 1 alkoxy -C4.

[52] A compound of formula I is preferred, where Ri, R2, R4, Rs, RÓ, R7, R9 and Rio are H and R3 and R8 are independently of each other H, C1-C8 alkyl or C1-C4 alkoxy .

[53] A compound of formula I is preferred, wherein Ri, R2, R4, Rs, RÓ, R7, R9 and Rio are H and R3 and R8 are independently of each other H or methoxy.

[54] A compound of formula I is preferred, where Ri, R2, R3, R4, Rs, RÓ, R7, Rs, R9 and Rio are H.

[55] A compound of formula I is preferred, where R'3 isHe R ”2 and R” 3 are H.

[56] A compound of formula I is preferred, where n is 1, 2 or 3.

[57] A compound of formula I is preferred, where n is 1 or 2.

[58] A compound of formula I is preferred, where when n is 1 A it is -C (= O) -OR'i, -C (= O) -N (R'2) (R'3), - CN, phenyl, which is substituted by one or more C1-Cs alkyl, C1-C4 alkoxy, C5-C7 cycloalkyl or halogen, -H or -SO2-phenyl.

[59] A compound of formula I is preferred, where when n is 1 A it is -C (= O) -OR'i, -C (= O) -N (R'2) (R'3), - CN, -H or -SO2- phenyl.

[60] A compound of formula I is preferred, where when n is 2 A it is -C (= O) -O-Zi-O-C (= O) -; when n is 3 A it is C3 -C12 alkane tri- (oxycarbonyl); when n is 4 A it is C4-C16 alkane tetra- (oxycarbonyl).

[61] A compound of formula I is preferred, where when n is 1 A it is -C (= O) -OR'i, -CN, phenyl, which is unsubstituted or substituted by one or more C 1 -C 6 alkyl, C1-C4 alkoxy, C5-C7 cycloalkyl or halogen, -H or -SO2-phenyl; when n is 2 A is -C (= O) -O-Zi-O-C (= O) -; when n is 3 A it is C3-C12 tri- (oxycarbonyl) alkane; when n is 4 A it is C4-C16 alkane tetra- (oxycarbonyl).

[62] A compound of formula I is preferred, where when n is 1 A it is -C (= O) -OR'i, -C (= O) -N (R'2) (R'3), - CN, phenyl, which is unsubstituted or substituted by one or more C1 -Cs alkyl, C1-C4 alkoxy, C5-C7 cycloalkyl or halogen, -H or -SCh-phenyl; when n is 2 A is -C (= O) -O-Zi-OC (= O) - or -C (= O) -N (R ”I) -Z2-N (R” 2) - C (= O)-; when n is 3 A it is C3-C12 tri- (oxycarbonyl) or 3-ethyl-3-azapentan-1,2,2'-tri- (oxycarbonyl) alkane; when n is 4 A it is C4-C16 alkane tetra- (oxycarbonyl); n is 1, 2, 3 or 4; Ri, R2, R3, R4, Rs, RÓ, R7, Rs, R9 and Rio are independently of each other H, C1-Cs alkyl, C4-C8 cycloalkyl, phenyl, C1-C4 alkoxy or halogen; R'i is H, C1-C22 alkyl, C2-C18 alkenyl, C3-C12 alkynyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-cycloalkyl C1-C4 , bicyclic or tricyclic C5-C20 alkyl, C6-C14 alkyl-C1-C4 alkyl, C2-C12 alkyl, which is replaced by one or more hydroxyl groups, C4-C12 alkyl, which is interrupted by one or more oxygen atoms, C4-C18 alkyl, which is interrupted by a sulfur atom, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (C1 -Cs alkyl) -2,2,6,6- tetramethylpiperidine-4-yl or 1- (C1-8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C1-22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, COC-CIO aryl, cycloalkyl C4-Cs-C1-C4 alkyl, C6-C14-C1-C4 alkyl, C2-C6 alkyl, which is replaced by a hydroxyl group, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (alkyl C1-Cs) -2,2,6,6-tetramethylpiperidine-4-yl or 1- (C1-C8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 form , together with the hydrogen atom to which they are attached to the 5, 6 or 7-membered saturated heterocycle; R ”i and R” 2 are independently of each other H, C-C22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-C1 cycloalkyl -C4, C6-C14 aryl-C1-C4 alkyl; Zi is C2-C12 alkylene, C4-C8 cycloalkylene, C4-C8-bis- (C1-C4 alkylene) cycloalkane, C6-C14 bis- (C1-C4 alkylene) arene, C3-C6 alkylene, which is replaced by one or more hydroxyl groups, C4-C12 alkylene, which is interrupted by one or more oxygen atoms, hexahydro-bore [3,2- b] furan-3,6-diyl, C4-C8 alkylene, which is interrupted by an atom of sulfur, 3- (C 1 -C 8 alkyl) -3-azapentane-1,5-diyl, 4- (C 1 -C 8 alkyl) -4-azaeptane-1,7-diyl or 1-ethyl-2,2,6, 6-tetramethylpiperidine-4,2'-diyl and Z2 is C2-C12 alkylene, C4-C8 cycloalkylene, CÓ-CH arylene, C4-C8-bis cycloalkane (C1-C4 alkylene), CÓ-CM bis- (C1 alkylene arylene) -C4), C4-C12 alkylene, which is interrupted by one or more oxygen atoms, 3- (C1-C8 alkyl) -3-azapentane-1,5-diyl or 4- (C1-C8 alkyl) -4- azaeptane-1,7-diyl.

[63] A compound of formula I is preferred, where when n is 1 A it is -C (= O) -OR'i OU-C (= O) -N (R'2) (R'3); when n is 2 A is -C (= O) -O-Zi-OC (= O) -, -C (= O) -N (R ”I) -Z2-N (R” 2) - C (= 0) - or piperazine-N, N'-biscarbonyl; when n is 3 A it is C3 -C12 alkane tri- (oxycarbonyl); when n is 4 A it is C4-C16 alkane tetra- (oxycarbonyl); n is 1, 2, 3 or 4; R1, R2, R3, R4, R5, R6, R7, Rs, R9 and Rio are independently of each other H, C1 -Cs alkyl, C4-C8 cycloalkyl, phenyl, C1-C4 alkoxy or halogen; R'I is H, C1-C22 alkyl, C2-C1 alkenyl, C3-C2 alkynyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-cycloalkyl C1 -C4, bicyclic or tricyclic C5-C2 alkyl, C6-C14 alkyl C1-C4 alkyl, C2-C12 alkyl, which is replaced by one or more hydroxyl groups, C4-C12 alkyl, which is interrupted by one or more carbon atoms oxygen, C4-C18 alkyl, which is interrupted by a sulfur atom, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (C 1 -Cs alkyl) -2,2,6,6- tetramethylpiperidine-4 -yl or 1- (C 1-8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C1-C22 alkyl, C2-C1 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or replaced by one to three C1-C4 alkyl, CIO-CIO aryl, cycloalkyl C4-C8-C1-C4 alkyl, C6-C14-C1-C4 alkyl, C2-C6 alkyl, which is replaced by a hydroxyl group, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (alkyl C1-Cs) -2,2,6,6- tetramethylpiperidine-4-yl or 1- (C1-8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 form , together with the hydrogen atom to which they are attached to the 5, 6 or 7-membered saturated heterocycle; R ”i and R” 2 are independently of each other H, C-C22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-Cs-C1 cycloalkyl -C4, C0-CU-aryl-C1-C4 alkyl; Zi is C2-C12 alkylene, C4-C8 cycloalkylene, C4-C8-bis- (C1-C4 alkylene) cycloalkane, CÓ-CU bis- (C1-C4 alkylene) arene, C3-C6 alkylene, which is replaced by one or more hydroxyl groups, C4-C12 alkylene, which is interrupted by one or more oxygen atoms, C4-C8 alkylene, which is interrupted by a sulfur atom and Z2 is C2-C12 alkylene, C4-C8 cycloalkylene, CÓ-CR arylene , C4-C8-bis cycloalkane (C1-C4 alkylene), CÓ-CU bis- arene (C1-C4 alkylene), C4-C12 alkylene, which is interrupted by one or more oxygen atoms, 3- (C1-Cs alkyl) ) -3-azapentan-1,5-diyl or 4- (C 1 -C 6 alkyl) -4-azaeptane-1,7-diyl.

[64] A composition is preferred, comprising a compound of formula I, where when n is 1 A it is -C (= O) -OR'i, -C (= O) -N (R'2) (R '3), -CN, phenyl, which is unsubstituted or substituted by one to three C 1 -C 6 alkyl or C 1 -C 4 alkoxy, -H or - SCh-phenyl; when n is 2 A is -C (= O) -O-Zi-OC (= O) -, -C (= O) -N (R '' I) -Z2-N (R ”2) - C ( = O) - or piperazine-N, N'-biscarbonyl; when n is 3 A is propane-1,2,3-tri- (oxycarbonyl), 2-methyl-propane-1,2,3-tri- (oxycarbonyl), 2-methyl-butane-1,2, r- tri- (oxycarbonyl), 2,2-dimethyl-butane-1,1 ', 1' '-tri- (oxycarbonyl), 2,2-dimethyl-pentane-1,1', 1 '' - tri- (oxycarbonyl ), 3-ethyl-3-azapentan-1,5,2'-tri- (oxycarbonyl); when n is 4 A it is 2,2-dimethyl-propane-1,3, r, l ”-tetra- (oxycarbonyl); n is 1, 2, 3 or 4; Ri, R2, R3, R4, Rs, RÓ, R7, Rs, R9 and Rio are independently of each other H, C1-Cs alkyl, phenyl or C1-C4 alkoxy with the proviso that at least Ri or Rs is H and at least RÓ or RIO is H; R'i is H, C1-C22 alkyl, C2-C18 alkenyl, C5-C7 cycloalkyl, which is unsubstituted or substituted by a C1-C4 alkyl, C5-C7 cycloalkyl-C1-C4 alkyl, C6-Cio-alkyl aryl C1-C4, C4-C12 alkyl, which is interrupted by one or more oxygen atoms, 2,2,6,6-tetramethylpiperidino-4-yl, 1- (C1- C alkyl) -2,2,6,6 -tetramethylpiperidine-4-yl or 1- (CI-COC alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C1- C22 alkyl, C2-C18 alkenyl, C5-C7 cycloalkyl, which is unsubstituted or substituted by C1-C4 alkyl, COC-CIO aryl, Cs- cycloalkyl C7-C1-C4 alkyl, aryl C1-C1-C1-C4 alkyl, 2,2,6,6-tetramethylpiperidino-4-yl, 1- (C1-COC alkyl) -2,2,6,6- tetramethylpiperidine- 4-yl or 1- (C 1 -C 6 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 form, together with the hydrogen atom to which they are attached to pyrrolidine, a piperidine or a morpholine; R ”ie R” 2 independently of each other H, C1-C22 alkyl, C2-C18 alkenyl, C5-C7 cycloalkyl, which is unsubstituted or replaced by C1-C4 alkyl, Cs-C7-C1-C4 cycloalkyl, aryl C 1 -C 10 -C 1 -C 4 alkyl; Zi is C2-C12 alkylene, C5-C7 cycloalkylene, C5-C7-bis- (C1-C4 alkylene) cycloalkane, COC-CIO bis- (C1-C4 alkylene) arene, C3-C6 alkylene, which is replaced by one or more hydroxyl groups, C4-C12 alkylene, which is interrupted by one or more oxygen atoms, C4-C8 alkylene, which is interrupted by a sulfur atom, 3- (C1-C4 alkyl) -3-azapentane-1,5 - diyl, 4- (C 1 -C 4 alkyl) -4-azaeptane-1,7-diyl or 1-ethyl-2,2,6,6-tetramethylpiperidine-4,2'-diyl and Z2 is C2-C12 alkylene, C5-C7 cycloalkylene, CÓ-CU arylene, Cs-C7-bis- cycloalkane (C1-C4 alkylene), CÓ-CIO bis- arene (C1-C4 alkylene), C4-C12 alkylene, which is interrupted by one or more atoms of oxygen, 3- (C 1 -C 4 alkyl) -3-azapentane-1,5-diyl or 4- (C 1 -C 4 alkyl) -4-azaeptane-1,7-diyl.

[65] A composition is preferred, comprising a compound of formula I, where when n is 1 A it is -C (= O) -OR'i, -C (= O) -N (R'2) (R '3), -CN, phenyl, which is unsubstituted or substituted by one or two C 1 -C 6 alkyl or C 1 -C 4 alkoxy, -H or -SO 2 -phenyl; when n is 2 A is -C (= O) -O-Zi-OC (= O) -, -C (= O) -N (R ”I) -Z2-N (R” 2) - C (= O) - or piperazine-N, N'-biscarbonyl; when n is 3 A is propane-1,2,3-tri- (oxycarbonyl), 2-methyl-propane-1,2,3-tri- (oxycarbonyl), 2-methyl-butane-1,2, r- tri- (oxycarbonyl), 2,2-dimethyl-butane-1,1 ', 1' '-tri- (oxycarbonyl), 2,2-dimethyl-pentane-1,1', 1 '' - tri- (oxycarbonyl ); when n is 4 A it is 2,2-dimethyl-propane-1,3, r, l ”-tetra- (oxycarbonyl); n is 1, 2, 3 or 4; Ri, R2, R4, Rs, RÓ, R7, R9 and Rio are H; R3 and Rs are independently of each other H, C1-Cs alkyl, C4-C8 cycloalkyl, phenyl, C1-C4 alkoxy or halogen; R'i is H, C1-C22 alkyl, C2-C1 alkenyl, C5-C7 cycloalkyl, which is unsubstituted, Cs-C7 cycloalkyl, C1-C4 alkyl, phenyl-C1-C4 alkyl, C4-C12 alkyl, which is interrupted by one or more oxygen atoms, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (CI-C6 alkyl) -2, 2,6,6-tetramethylpiperidine-4-yl or 1- (alkoxy C1-C6) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C-C22 alkyl, C2-C18 alkenyl, C5-C7 cycloalkyl, which is unsubstituted, C6-Cio aryl, Cs-Cyalkyl C1-C4 cycloalkyl, phenyl-alkyl C1-C4, 2,2,6,6-tetramethylpiperidine-4-yl, 1 - (C1-C6 alkyl) -2,2,6,6-tetramethylpiperidine-4-yl or 1- (C1-C6 alkoxy) - 2,2,6,6-tetramethylpiperidino-4-yl or R'2 and R'3 forms, together with the hydrogen atom to which they are attached to pyrrolidine, a piperidine or a morpholine; R ”i and R” 2 are independently of each other H, C1-C22 alkyl, C2-C18 alkenyl, C5-C7 cycloalkyl, which is unsubstituted, C5-C7-C1-C4-cycloalkyl or C1-C4-phenyl-alkyl; Zi is C2-C12 alkylene, C5-C7 cycloalkylene, C5-C7-bis- (C1-C4 alkylene) cycloalkane, benzene-bis- (C1-C4 alkylene), C3-C6 alkylene, which is replaced by one or more groups hydroxyl, C4-C12 alkylene, which is interrupted by one or more oxygen atoms, C4-C8 alkylene, which is interrupted by a sulfur atom, 3- (C 1 -C 4 alkyl) -3-azapentane-1, 5-diyl , 4- (C1 -C4 alkyl) -4-azaeptane-1,7-diyl or l-ethyl-2,2,6,6-tetramethylpiperidine-4,2'-diyl and Z2 is C2-C12 alkylene, C5 cycloalkylene -C7, CÓ-CR arylene, Cs-C7-bis cycloalkane (C1-C4 alkylene), benzene-bis- (C1-C4 alkylene), C4-C12 alkylene, which is interrupted by one or more oxygen atoms, 3- (C 1 -C 4 alkyl) -3-azapentan-1,5-diyl or 4- (C 1 -C 4 alkyl) -4-azaeptane-1,7-diyl.

[66] A composition is preferred, which comprises a compound of formula I, where n is 1; A is -CN, phenyl or -H and Ri, R2, R3, R4, Rs, RÓ, R7, Rs, RÇ and Rio are independently of each other H, C1 -Cs alkyl, C4-C8 cycloalkyl, phenyl, C1 alkoxy -C4 or halogen.

[67] A composition is preferred, which comprises a compound of formula I, where in formula I when n is 1 A is -C (= O) -OR'i, -C (= O) -N (R'2 ) (R'3), -CN, phenyl, -H or -SO2-phenyl; when n is 2 A is -C (= O) -O-Zi-O-C (= O) -; n is 1 or 2; Ri, R2, R4, Rs, RÓ, R7, Rç o Rio are H; R3 and Rs are independently of each other H or C1-4 alkoxy; R'i is H, C1 -C2 alkyl, C5-C7 cycloalkyl, which is unsubstituted, phenyl-C1-C4 alkyl, 1- (C1-C6 alkyl) -2,2,6,6-tetramethylpiperidine-4-yl or 1- (C 1 -C 6 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C1-C2 alkyl, C5-C7 cycloalkyl, which is unsubstituted, C6-C10 aryl, C1-C4 phenyl-alkyl, 1- (C1-C6 alkyl) - 2,2,6,6-tetramethylpiperidine-4-yl or 1- (CI-COC alkoxy) - 2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 forms, together with the atom of hydrogen to which they are attached to pyrrolidine, a piperidine or a morpholine and Zi is C5-C7 cycloalkylene.

[68] A composition is preferred, which comprises a compound of formula I, where when n is 1 A it is -C (= O) -OCH3, -CN, phenyl or -H; when n is 2 A is -C (= O) -O-Zi-O-C (= O) -; n is 1 or 2; Ri, R2, R3, R4, Rs, RÓ, R7, Rs, R9 and Rio are H and Zi is cyclohexane-1,4-diyl.

[69] The organic material of the present invention is susceptible to thermal degradation or induced by oxidative light.

[70] Examples of an organic material are: 1. Polymers of monoolefins and diolefins, for example, polypropylene, polyisobutylene, polybut-l-ene, poly-4-methylpent-l-ene, polyvinylcyclohexane, polyisoprene or polybutadiene, as well as polymers of cycloolefins, for example, cyclopentene or nor-bornene, polyethylene (which can optionally be cross-linked), for example, high density polyethylene (HDPE), high density polyethylene (HDPE- HMW), high density and ultrahigh molecular weight polyethylene (HDPE- UHMW), medium density polyethylene (MDPE), low density polyethylene (LDPE), low density linear polyethylene (LLDPE), (VLDPE) and (ULDPE) .

[71] Polyolefins, that is, the monoolefin polymers exemplified in the preceding paragraph, preferably polyethylene and polypropylene, can be prepared by different methods and especially the following methods: a) radical polymerization (usually under high pressure and an elevated temperature). b) catalytic polymerization using a catalyst that normally contains one or more than one metal of groups IVb, Vb, VIb or VIII of the Periodic Table. These metals usually have one or more than one ligand, typically oxides, halides, alcoholates, esters, ethers, amines, alkyls, alkenyls and / or aryls that can be π- or σ-coordinated. These metal complexes can be in free or fixed form on the substrates, typically in activated magnesium chloride, titanium (III) chloride, alumina or silicon oxide. These catalysts can be soluble or insoluble in the polymerization medium. Catalysts can be used alone in the polymerization or additional activators can be used, typically metal alkyls, metal hydrides, metal alkyl halides, metal alkyl oxides or metal alkyloxanes, said metals being the elements of groups Ia, Ila and / or Ilia from the Periodic Table. The activators can be conveniently modified with additional ester, ether, amine or silyl groups. These catalyst systems are usually called Phillips, Standard Oil Indiana, Ziegler (-Natta), TNZ (DuPont), metallocene or single-site catalysts (SSC). 2. Mixtures of the polymers mentioned under 1), for example, mixtures of polypropylene with polyisobutylene, polypropylene with polyethylene (for example, PP / HDPE, PP / LDPE) and mixtures of different types of polyethylene (for example, LDPE / HDPE ). 3. Copolymers of monoolefins and diolefins with each other or with other vinyl monomers, for example, ethylene / propylene copolymers, low density linear polyethylene (LLDPE) and mixtures thereof with low density polyethylene (LDPE), propylene copolymers / but-l-ene, propylene / isobutylene copolymers, ethylene / but-l-ene copolymers, ethylene / hexene copolymers, ethylene / methylpentene copolymers, ethylene / heptene copolymers, ethylene / octene copolymers, copolymers / vinylcyclohexane, ethylene / cycloolefin copolymers (eg COC-like ethylene / norbornene), ethylene / l-olefin copolymers, where 1-olefin is generated in situ ', propylene / butadiene copolymers, isobutylene / isoprene copolymers , ethylene / vinylcyclohexene copolymers, ethylene / alkyl acrylate copolymers, ethylene / alkyl methacrylate copolymers, ethylene / vinyl acetate copolymers or ethylene / acrylic acid copolymer and their salts (ionomers) as well as ethylene terpolymers with propylene and a diene such as hexadiene, dicyclopentadiene or ethylidane-norbornene and mixtures of such copolymers with one another and with the polymers mentioned in 1) above, for example, polypropylene / ethylene-propylene copolymers, copolymers of LDPE / ethylene vinyl acetate (EVA) copolymers, LDPE / ethylene-acrylic acid (EAA) copolymers, LLDPE / EVA, LLDPE / EAA and alternating or random polyalkylene / carbon monoxide copolymers and mixtures of them with other polymers , for example, polyamides.

[72] A special two-monoolefin copolymer is a random tube-grade copolymer, which is obtainable from the polymerization of more than 90% by weight of propylene and less than 10% by weight, typically between 2 and 6% by weight of ethylene. 4. Hydrocarbon resins (eg, C5-C9) including hydrogenated modifications thereof (eg, thickeners) and mixtures of polyalkylene and starch.

[73] The homopolymers and copolymers of 1.) - 4.) can have any stereostructure including syndiotactic, isotactic, hemi-isotactic or atactic; where atactic polymers are preferred. Stereoblock polymers are also included. 5. Polystyrene, poly (p-methylstyrene), poly (oc-methylstyrene). 6. Aromatic homopolymers and copolymers derived from aromatic vinyl monomers including styrene, oc-methyl styrene, all toluene vinyl isomers, especially p-vinyl-toluene, all ethyl styrene, propylene styrene, vinyl biphenyl, naptalene vinyl and vinyl anthracene, and mixtures thereof. Homopolymers and copolymers can have any stereostructure including syndiotactic, isotactic, hemisisotactic or atactic; where atactic polymers are preferred. Stereoblock polymers are also included. 6th. Copolymers including previously mentioned aromatic vinyl monomers and comonomers selected from ethylene, propylene, dienes, nitriles, acids, maleic anhydrides, maleimides, vinyl acetate and vinyl chloride or acrylic derivatives and mixtures thereof, for example, styrene / butadiene, styrene / acrylonitrile, styrene / ethylene (interpolymers), styrene / alkyl methacrylate, styrene / butadiene / alkyl acrylate, styrene / butadiene / alkyl methacrylate, styrene / maleic anhydride, styrene / acrylonitrile / methyl acrylate; high impact strength mixtures of styrene copolymers and another polymer, for example, a polyacrylate, a diene polymer or an ethylene / propylene / diene thermopolymer and styrene block copolymers such as styrene / butadiene / styrene, styrene / isoprene / styrene, styrene / ethylene / butylene / styrene or styrene / ethylene / propylene / styrene. 6b. Hydrogenated aromatic polymers derived from the hydrogenation of the polymers mentioned under 6.), in particular including polycholichexylethylene (PCHE) prepared by the hydrogenation of the atypical polystyrene, often referred to as polyvinylcyclohexane (PVCH). 6c. Hydrogenated aromatic polymers derived from the hydrogenation of the polymers mentioned under 6a.).

[74] Homopolymers and copolymers can have any stereostructure including syndiotactic, isotactic, hemi-isotactic or atactic; where atactic polymers are preferred. Stereoblock polymers are also included. 7. Graft copolymers of aromatic vinyl monomers such as styrene or oc-methylstyrene, for example, styrene in polybutadiene, styrene in polybutadiene-styrene or polybutadiene-acrylonitrile copolymers; styrene and acrylonitrile (or methacrylonitrile) in polybutadiene; styrene, acrylonitrile and methyl methacrylate in polybutadiene; styrene and maleic anhydride in polybutadiene; styrene, acrylonitrile and maleic anhydride or maleimide in polybutadiene; styrene and maleimide in polybutadiene; styrene and alkyl acrylates or polybutadiene methacrylates; styrene and acrylonitrile in ethylene / propylene / diene terpolymers; styrene and acrylonitrile in polyalkyl acrylates or polyalkyl methacrylates, styrene and acrylonitrile in acrylate / butadiene copolymers, as well as mixtures of these with the copolymers listed under 6), for example, the copolymer mixtures known as ABS polymers, MBS, ASA or AES. 8. Halogen-containing polymers such as Polycoloprene, chlorinated rubbers, isobutylene-isoprene chlorinated and bromide copolymer (halobutyl rubber), chlorinated or sulfochlorinated polyethylene, chlorinated ethylene and ethylene copolymers, homo and epichlorohydrin copolymers, especially polymers of vinyl compounds containing halogen, for example, Polyvinyl chloride, polyvinylidane chloride, polyvinyl fluoride, polyvinylidane fluoride, as well as copolymers such as vinyl chloride / vinylidane chloride, vinyl chloride / vinyl acetate or vinylidane chloride copolymers / vinyl acetate. 9. Polymers derived from α, β-unsaturated acids and derivatives thereof such as polyacrylates and polymethacrylates; polymethyl methacrylates, polyacrylamides and polyacrylonitriles, impact modifiers with butyl acrylate. 10. Copolymers of the monomers mentioned under 9) with each other or with other unsaturated monomers, for example, acrylonitrile / butadiene copolymers, acrylonitrile / alkyl acrylate copolymers, acrylonitrile / acrylonitrile or acrylonitrile acrylate or acrylonitrile acrylates or acrylonitrile acrylates / acrylonitrile / halide acrylate / acrylonitrile / acrylonitrile / acrylonitrile / halide acrylates / acrylonitrile / halide acrylates / acrylonitrile / acrylonitrile / acrylonitrile / halide compounds / acrylonitrile / alkyl methacrylate / butadiene. 11. Polymers derived from unsaturated alcohols and amines or those derived from acyl or acetals thereof, for example, polyvinyl alcohol, vinyl polyacetate, polyvinyl stearate, polyvinyl benzoate, polyvinyl maleate, polyvinyl butyl, polyalyl phthalate or polyalyl melamine ; as well as its olefin copolymers mentioned in 1) above. 12. Homopolymers and copolymers of cyclic esters such as polyalkylene glycol, polyethylene oxide, polypropylene oxide or copolymers of these with bisglycidyl esters. 13. Polyacetals such as polyoxymethylene and those polyoxymethylenes in which it contains ethylene oxide as a comonomer; polyacetals modified with thermoplastic polyurethanes, acrylates or MBS. 14. Polyphenylene oxides and sulfides and mixtures of polyphenylene oxides with styrene polymers or polyamides. 15. Polyurethanes, for example, polyurethanes synthesized from a polyol and an aliphatic or aromatic polyisocyanate such as polyurethanes derived from hydroxyl-terminated polyethers, polyesters or polybutadienes on the one hand and aliphatic or aromatic polyisocyanates on the other, and precursors thereof .

[75] Hydroxyl-terminated polyesters are known and are prepared, for example, by polymerizing epoxides such as ethylene oxide, propylene oxide, butylene oxide, tetrahydrofuran, styrene oxide or epichlorohydrin with their own, for example, in presence of BF3, or by the addition reaction of these epoxides, alone or as a mixture or in succession, with starting components containing reactive hydrogen atoms, such as water, alcohols, ammonia or amines, for example, ethylene glycol, propylene 1, 3- and 1,2-glycol, trimethylolpropane, 4,4'-dihydroxydiphenylpropane, aniline, ethanolamine or ethylenediamine. Sucrose polyethers are also suitable according to the invention. In many cases, preference is given to those polyethers in which predominantly (up to 90% by weight, based on all of the OH groups present in the polyether) contain the primary OH groups. In addition, polyethers modified by vinyl polymers, as they are formed, for example, by the polymerization of styrene and acrylonitrile in the presence of polyethers, are suitable, as are polybutadiene containing OH groups.

[76] In particular, a polyol compound has a molecular weight of 400-10000, especially 800 to 10,000 and is a polyhydroxy compound, especially containing from 2 to 8 hydroxyl groups, especially from 2 to 4.

[77] Suitable polyisocyanates are aliphatic or aromatic, for example, ethylene diisocyanate, 1,4-tetramethylene diisocyanate, 1,6-hexamethylene diisocyanate, 1,12-dodecane diisocyanate, 1,3-diisocyanate cyclobutane, 1,3- and -1,4-cyclohexane diisocyanate and also any desired mixtures of these isomers, l-isocyanate-3,3,5-trimethyl-5-isocyanatomethylcyclohexane, 2,4- and 2,6- diisocyanate hexahydrotolylene and also any desired mixtures of these isomers, hexahydro-1,3- and / or -1,4-phenylene diisocyanate, perhydro-2,4'- and / or -4,4'- diphenylmethanediisocyanate, 1,3 diisocyanate - and 1,4-phenylene, 2,4- and 2,6-tolylene diisocyanate and also any mixtures of these isomers, 2,4'- and / or -4,4'-diisocyanate, 1,5-diisocyanate naptilene, 4,4 ', 4 ”-triphenylmethane triisocyanate, polyphenylpolymethylene polyisocyanates as obtained by condensation of aniline-formaldehyde followed by phosgenisation, m- and p-isocyanatophenylsulfonyl isocyanates , perchlorinated aryl polyisocyanates, polyisocyanates containing carbodiimide groups, polyisocyanates containing allophanate groups, polyisocyanates containing isocyanurate groups, polyisocyanates containing urethane groups, polyisocyanates containing acylated urea groups, poly -isocyanates containing biuret groups, polyisocyanates containing ester groups, reaction products of the aforementioned isocyanates with acetals and polyisocyanates containing polymeric fatty acid radicals.

[78] It is also possible to use an isocyanate group containing distillation residues, as these are either dissolved in one or more of the polyisocyanates previously mentioned, which are obtained in the course of industrial preparation of isocyanates. It is additionally possible to use any desired mixtures of the polyisocyanates mentioned above.

[79] Preferred are 2,4- or 2,6-tolylene diisocyanate and any desired mixtures of these isomers (“TDI”), polyphenyl-polymethylene-polyisocyanates as prepared by condensation of aniline-formaldehyde followed by phosgenization (“MDI crude ”) or polyisocyanates containing groups of carbodiimide, urethane, allophanate, isocyanurate, urea or biuret (“ modified polyisocyanates ”).

[80] Polyurethanes can be homogeneous or cellular polyurethanes. 16. Polyamides and copolyamides derived from diamines and dicarboxylic acids and / or aminocarboxylic acids or the corresponding lactams, for example, polyamide 4, polyamide 6, polyamide 6/6, 6/10, 6/9, 6/12, 4 / 6, 12/12, polyamide 11, polyamide 12, starting from aromatic polyamides of m-xylene diamine and adipic acid; polyamides prepared from hexamethylenediamine and isophthalic and / or terephthalic acid and with or without an elastomer as a modifier, for example, poly-2,4,4, -trimethylexamethylene tereptalamide or poly-m-phenylene isoptalamide and also block copolymers of the aforementioned polyamides with polyolefins, olefin copolymers, ionomers or elastomers chemically bonded or grafted; or with polyethers, for example, with polyethylene glycol, polypropylene glycol or polytetramethylene glycol; as well as polyamides or copolyamides modified with EPDM or ABS and condensed polyamides during processing (RIM polyamide systems). 17. Polyureas, polyimides, polyamide-imides, polyetherimides, polyesterimides, poly-idantoins and polybenzimidazoles. 18. Polyesters derived from dicarboxylic acids and diols and / or from the corresponding hydroxycarboxylic acids or lactones or lactides, for example, polyethylene terephthalate, polybutylene terephthalate, poly-l, 4-dimethylolcyclohexane, polyalkylene naphthalate and poly-idroxibenzoates as copolyether esters derived from hydroxyl-terminated polyethers and also polyesters modified with Policoarbonates or MBS. Copolyesters may comprise, for example, - but are not limited to - polybutylenesuccinate / terephthalate, polybutylene adipate / terephthalate, polytetramethylenoadipate / terephthalate, polybutylensuccinate / adipate, polybutylensuccinate / carbonate, poly-3-hydroxy butane poly-polymer polyol copolymer, hydroxybutyrate / hexanoate / decanoate. In addition, aliphatic polyesters may comprise, for example, - but are not limited to - the class of poly (hydroxyalkanoates), in particular, poly (propiolactone), poly (butyrolactone), poly (pivalolactone), poly (valerolactone) and poly (caprolactone), polietilenosuccinato, polipropilenosuccinato, polibutilenosuccinato, poliexametilenosuccinato, polietilenoadipato, polipropilenoadipato, polibutilenoadipato, poliexametilenoadipato, polietilenooxalato, polipropilenooxalato, polibutilenooxalato, poliexametilenooxalato, polietilenosebacato, polipropilenosebacato, polibutilenosebacato and polylactic acid (PLA) as well as corresponding polyesters modified with Policoarbonatos or MBS. The term "polylactic acid (PLA)" indicates a homo-polymer of preferably poly-L-lactide and any of its combinations or alloys with other polymers; a copolymer of lactic acid or lactide with other monomers, such as hydroxy carboxylic acids, similar for example, glycolic acid, 3-hydroxy-butyric acid, 4-hydroxy-butyric acid, 4-hydroxy-valeric acid, 5-hydroxy acid -valeric, 6-hydroxy-capranoic acid and cyclic forms thereof; the terms "lactic acid" or "lactide" include L-lactic acid, D-lactic acid, mixtures and dimers thereof, i.e. L-lactide, D-lactide, meso-lactide and any mixtures thereof. 19. Polycarbonates and polyester carbonates. 20. Polyketones. 21. Polysulfones, polyether sulfones and polyether ketones. 22. Polymers derived from crosslinked aldehydes on the one hand, phenols, urea and melamines in another way, such as phenol / formaldehyde resins, urea / formaldehyde resins and melamine / formaldehyde resins. 23. Drying and non-drying of alkyd resins. 24. Unsaturated polyester resins derived from saturated and unsaturated dicarboxylic acid copolyesters with polyhydric alcohols and vinyl compounds as crosslinking agents and also halogen-containing modifications of these of low flammability. 25. Crosslinkable acrylic resins derived from substituted acrylates, for example, epoxy acrylates, urethane acrylates or polyester acrylates. 26. Alkyd resins, polyester resins and acrylate resins crosslinked with melamine resins, urea resins, isocyanates, isocyanurates, polyisocyanates or epoxy resins. 27. Cross-linked epoxy resins derived from aliphatic, cycloaliphatic, heterocyclic or aromatic glycidyl compounds, for example, products of diglycidyl ethers of bisphenol A and bisphenol F, which are cross-linked with usual hardeners such as anhydrides or amines, with or without accelerators. 28. Natural polymers such as cellulose, rubber, gelatin and chemically modified homologous derivatives thereof, for example, cellulose acetates, cellulose propionates and cellulose butyrates, or cellulose ethers such as methyl cellulose; as well as rosinas and their derivatives. 29. Combinations of the aforementioned polymers (poly-combinations), for example, PP / EPDM, polyamide / EPDM or ABS, PVC / EVA, PVC / ABS, PVC / MBS, PC / ABS, PBTP / ABS, PC / ASA, PC / PBT, PVC / CPE, PVC / acrylates, thermoplastic POM / PUR, thermoplastic PC / PUR, POM / acrylate, POM / MBS, PPO / HIPS, PPO / PA 6.6 and copolymers, PA / HDPE, PA / PP, PA / PPO , PBT / PC / ABS or PBT / PET / PC. 30. Synthetic and naturally occurring organic materials that are pure monomeric compounds or mixtures of such compounds, for example, mineral oils, animal and vegetable fats, oil and waxes, or oils, fats and waxes based on synthetic esters (for example, phthalates, adipates, phosphates or trimellites) and also mixtures of synthetic esters with mineral oils in any weight ratios, typically those used as spinning compositions, as well as aqueous emulsions of such materials. 31. Aqueous emulsions of synthetic or natural rubber, for example, natural latex or lattices of carboxylated styrene / butadiene copolymers.

[81] A polymer can be natural, semi-synthetic or synthetic. A natural polymer is isolated from the natural source without further synthetic modifications. A synthetic polymer does not contain a polymer part isolated from the natural source. A semi-synthetic polymer contains at least a part of natural polymer, where the part of natural polymer can be synthetically modified and / or reacted with the monomers to form the semi-synthetic polymer.

[82] A polymer can be thermoplastic, that is, it can be formed in a new form at an elevated temperature, for example, at a temperature in the range of 150 ° C to 340 ° C.

[83] A composition is preferred, comprising component a) an organic material, in which the organic material is selected from the group consisting of a polymer, a wax, a mineral oil and a fat and a component b).

[84] A composition is preferred, comprising component a) a polymer, in particular a semi-synthetic or synthetic polymer and component b) a compound of formula I.

[85] A composition is preferred, comprising component a) a semi-synthetic or synthetic polymer.

[86] A composition is preferred, comprising component a) a thermoplastic polymer.

[87] A composition, comprising component a) a polymer, which is synthetic and thermoplastic is preferred.

[88] A composition is preferred, comprising component a) a polyolefin, a polyether polyol or a polyurethane.

[89] The amount of component b) used in relation to component a) varies with the particular organic material and the desired degree of protection.

[90] A composition is preferred, comprising a component a) and a component b), in which component b) is contained in an amount of 0.0005% to 10%, in particular 0.001 to 2%, especially of 0.005 to 1%, based on the weight of component a).

[91] Optionally, a composition comprises a component a) and a component b) contains as component c) an additional additive.

onde R’ = 3'-terc-butil-4'-hidróxi-5'-2H-benzotriazol-2-ilfenila, 2-[2'-hidróxi- 3'-(oc,oc-dimetilbenzil)-5'-(l, 1,3,3-tetrametilbutil)fenil]benzotriazol; 2-[2'- hidróxi-3'-(l, 1,3,3-tetrametilbutil)-5'-(oc,oc-dimetilbenzil)fenil]benzotriazol. 2.2. 2-Hidroxibenzofenonas, por exemplo, os derivados de 4- hidróxi, 4-metóxi, 4-octilóxi, 4-decilóxi, 4-dodecilóxi, 4-benzilóxi, 4,2',4'- triidróxi e 2'-hidróxi-4,4'-dimetóxi. 2.3. Ésteres de ácidos benzóicos substituídos e não substituídos, por exemplo, salicilato de 4-terc-butilfenila, salicilato de fenila, salicilato de octilfenila, dibenzoil resorcinol, bis(4-terc- butilbenzoil)resorcinol, benzoil resorcinol, 3,5-di-terc-butil-4-hidroxibenzoato de 2,4-di-terc-butilfenila, 3,5-di-terc-butil-4-hidroxibenzoato de hexadecila, 3,5-di-terc-butil-4-hidroxibenzoato de octadecila, 3,5-di-terc-butil-4- hidroxibenzoato de 2-metil-4,6-di-terc-butilfenila. 2.4. Acrilatos, por exemplo, oc-ciano-β,β-difenilacrilato de etila, oc-ciano-β,β-difenilacrilato de iso-octila, oc-carbometoxicinamato de metila, oc-ciano-β-metil-p-metoxicinamato de metila, α-ciano-β-metil-p- metoxicinnamato de butila, oc-carbometóxi-p-metoxicinamato de metila, N- (β-carbomet0xi-β-cianovinil)-2-metilindolina e neopentil tetra(oc-ciano-β,β- difenilacrilato). 2.5. Compostos de níquel, por exemplo, complexos de níquel de 2,2'-tiobis[4-(l,l,3,3-tetrametilbutil)fenol], tal como o complexo 1:1 ou 1:2, com ou sem ligandos adicionais tal como n-butilamina, trietanolamina ou N-cicloexildietanolamina, dibutilditiocarbamato de níquel, sais de níquel dos monoalquil ésteres, por exemplo, o metil ou etil éster, de ácido 4-hidróxi-3,5- di-terc-butilbenzilfosfônico, complexos de níquel de cetoximas, por exemplo, de 2-hidróxi-4-metilfenilundecilcetoxima, complexos de níquel de l-fenil-4- lauroil-5-hidroxipirazol, com ou sem ligandos adiciomais. 2.6. Aminas estericamente impedidas, por exemplo, bis(2,2,6,6-tetrametil-4-piperidil)sebacato, bis(2,2,6,6-tetrametil-4- piperidil)succinato, bis( 1,2,2,6,6-pentametil-4-piperidil)sebacato, bis (1,2,2,6,6-pentametil-4-piperidila) n-butil-3,5-di-terc-butil-4- hidroxibenzilmalonato, o condensado de l-(2-hidroxietil)-2,2,6,6-tetrametil-4- hidroxipiperidina e ácido succínico, condensados lineares ou cíclicos de N,N'- bis(2,2,6,6-tetrametil-4-piperidil)hexametilenodiamina e 4-terc-octilamino- 2,6-dicloro-l,3,5-triazina, tris(2,2,6,6-tetrametil-4-piperidil)nitrilotriacetato, tetraquis(2,2,6,6-tetrametil-4-piperidil)-1,2,3,4-butanotetracarboxilato, 1,1’- (l,2-etanodiil)-bis(3,3,5,5-tetrametilpiperazinona), 4-benzoil-2,2,6,6- tetrametilpiperidino, 4-estearilóxi-2,2,6,6-tetrametilpiperidino, bis( 1,2,2,6,6- pentametilpiperidil)-2-n-butil-2-(2-hidróxi-3,5-di-terc-butilbenzil)malonato, 3-n-octil-7,7,9,9-tetrametil-l,3,8-triazaspiro[4.5]decano-2,4-diona, bis(l - octilóxi-2,2,6,6-tetrametilpiperid-4-il)sebacato, bis(l-octilóxi-2,2,6,6- tetrametilpiperid-4-il)succinato, bis-[2,2,6,6-tetrametil-l-(undecilóxi)- piperidin-4-il] carbonato, condensados lineares ou cíclicos de N,N'- bis(2,2,6,6-tetrametil-4-piperidil)-hexametilenodiamina e 4-morfolino-2,6- dicloro-l,3,5-triazina, o condensado de 2-cloro-4,6-bis(4-n-butilamino- 2,2,6,6-tetrametilpiperidil)-1,3,5-triazina e 1,2-bis(3-aminopropilamino)etano, o condensado de 2-cloro-4,6-di-(4-n-butilamino-1,2,2,6,6- pentametilpiperidil)-l,3,5-triazina e l,2-bis(3-aminopropil-amino)etano, 8- acetil-3-dodecil-7,7,9,9-tetrametil-l,3,8-triazaspiro[4.5]decano-2,4-diona, 3- dodecil-l-(2,2,6,6-tetrametil-4-piperidil)pirrolidina-2,5-diona, 3-dodecil-l- (l,2,2,6,6-pentametil-4-piperidil)pirrolidina-2,5-diona, uma mistura de 4- hexadecilóxi- e 4-estearilóxi-2,2,6,6-tetrametilpiperidino, um condensado de N,N'-bis(2,2,6,6-tetrametil-4-piperidil)hexametilenodiamina e 4- cicloexilamino-2,6-dicloro-l,3,5-triazina, um condensado de l,2-bis(3- aminopropilamino)etano e 2,4,6-tricloro-l,3,5-triazina bem como 4- butilamino-2,2,6,6-tetrametilpiperidino (CAS Reg. N°. [136504-96-6]); um condensado de 1,6-hexanodiamina e 2,4,6-tricloro-l,3,5-triazina bem como N,N-dibutilamina e 4-butilamino-2,2,6,6-tetrametilpiperidino (CAS Reg. N°. [192268 64-7]); N-(2,2,6,6-tetrametil-4-piperidil)-n-dodecilsuccinimida, N- (l,2,2,6,6-pentametil-4-piperidil)-n-dodecilsuccinimida, 2-undecil-7,7,9,9- tetrametil-l-oxa-3,8-diaza-4-oxo-espiro[4,5]decano, um produto de reação de 7,7,9,9-tetrametil-2-cicloundecil-1 -oxa-3,8-diaza-4-oxospiro- [4,5 ] decano e epicloroidrina, 1,1 -bis( 1,2,2,6,6-pentametil-4-piperidiloxicarbonil)-2-(4- metoxifenil)-eteno, N,N'-bis-formil-N,N'-bis(2,2,6,6-tetrametil-4- piperidil)hexametilenodiamina, um diéster do ácido 4- metoximetilenomalônico com 1,2,2,6,6-pentametil-4-hidróxi-piperidina, poli[metilpropil-3-óxi-4-(2,2,6,6-tetrametil-4-piperidil)]siloxano, um produto de reação de ácido maleico do copolímero de anidrido-oc-olefina com 2,2,6,6- tetrametil-4-aminopiperidina ou l,2,2,6,6-pentametil-4-aminopiperidina, uma mistura de compostos oligoméricos que são os produtos de condensação formal de N,N’-bis-(2,2,6,6-tetrametil-l-propóxi-piperidin-4-il)-hexano-l,6- diamina e 2,4-dicloro-6- {n-butil-(2,2,6,6-tetrametil-1 -propóxi-piperidin-4-il)- amino]-[l,3,5]triazina e revestido final com 2-cloro-4,6-bis-(di-n- butilamino)-[l,3,5]triazina, uma mistura de compostos oligoméricos que são os produtos de condensação formal de N,N’-bis-(2,2,6,6-tetrametil-piperidin- 4-il)-hexano-1,6-diamina e 2,4-dicloro-6- {n-butil-(2,2,6,6-tetrametil- piperidin-4-il)-amino]-[l,3,5]triazina revestido final com 2-cloro-4,6-bis-(di- n-butilamino)-[l,3,5]triazina, 2,4-bis[N-(l-cicloexilóxi-2,2,6,6- tetrametilpiperidino-4-il)-N-butilamino]-6-(2-hidroxietil)amino-l,3,5-triazina, l-(2-hidróxi-2-metilpropóxi)-4-octadecanoilóxi-2,2,6,6-tetrametilpiperidino, 5-(2-etilexanoil)oximetil-3,3,5-trimetil-2-morfolinona, Sanduvor (Clariant; CAS Reg. N°. 106917-31-1], 5-(2-etilexanoil)-oximetil-3,3,5-trimetil-2- morfolinona, o produto de reação de 2,4-bis-[(l-ciclo-hexilóxi-2,2,6,6- piperidina-4-il)butilamino]-6-cloro-s-triazina com N,N’-bis-(3-amino- propil)etilenodiamina), l,3,5-tris(N-cicloexil-N-(2,2,6,6-tetrametil- piperazino-3-ona-4-il)amino)-s-triazina, 1,3,5-tris(N-cicloexil-N-(l,2,2,6,6- pentametilpiperazino-3-ona-4-il)-amino)-s-triazina. 2.7. Oxamidas, por exemplo, 4,4'-dioctiloxioxanilida, 2,2'- dietoxioxanilida, 2,2'-dioctilóxi-5,5'-di-terc-butoxanilida, 2,2'-didodecilóxi- 5,5 '-di-terc-butoxanilida, 2-etóxi-2'-etiloxanilida, N,N'-bis (3 - dimetilaminopropil)oxamida, 2-etóxi-5-terc-butil-2'-etoxanilida e sua mistura com 2-etóxi-2'-etil-5,4'-di-terc-butoxanilida, misturas de oxanilidas disubstituídas por o- e p-metóxi e misturas de oxanilidas disubstituidas por o- e p-etóxi. 2.8. 2-(2-Hidroxifenil)-l,3,5-triazinas, por exemplo, 2,4,6- tris(2-hidróxi-4-octiloxifenil)-l,3,5-triazina, 2-(2-hidróxi-4-octiloxifenil)-4,6- bis(2,4-dimetilfenil)-l ,3,5-triazina, 2-(2,4-di-hidroxifenil)-4,6-bis(2,4- dimetilfenil)-l,3,5-triazina, 2,4-bis(2-hidróxi-4-propiloxifenil)-6-(2,4- dimetilfenil)-l,3,5-triazina, 2-(2-hidróxi-4-octiloxifenil)-4,6-bis(4-metilfenil)- 1,3,5-triazina, 2-(2-hidróxi-4-dodeciloxifenil)-4,6-bis(2,4-dimetilfenil)-l ,3,5- triazina, 2-(2-hidróxi-4-trideciloxifenil)-4,6-bis(2,4-dimetilfenil)-1,3,5- triazina, 2-[2-hidróxi-4-(2-hidróxi-3-butiloxipropóxi)fenil]-4,6-bis(2,4- dimetil)-l,3,5-triazina, 2-[2-hidróxi-4-(2-hidróxi-3-octiloxipropilóxi)fenil]- 4,6-bis(2,4-dimetil)-1,3,5-triazina, 2-[4-(dodeciloxi/tridecilóxi-2- hidroxipropóxi)-2-hidroxifenil]-4,6-bis(2,4-dimetilfenil)-1,3,5-triazina, 2- [2- hidróxi-4-(2-hidróxi-3-dodeciloxipropóxi)fenil]-4,6-bis(2,4-dimetilfenil)- 1,3,5-triazina, 2-(2-hidróxi-4-hexilóxi)fenil-4,6-difenil-l ,3,5-triazina, 2-(2- hidróxi-4-metoxifenil)-4,6-difenil-1,3,5 -triazina, 2,4,6-tris [2-hidróxi-4- (3 - butóxi-2-hidroxipropóxi)fenil]-1,3,5-triazina, 2-(2-hidroxifenil)-4-(4- metoxifenil)-6-fenil-1,3,5 -triazina, 2- {2-hidróxi-4- [3 -(2-etilexil-1 -óxi)-2- hidroxipropilóxi]fenil }-4,6-bis->(2,4-dimetilfenil)-1,3,5-triazina. 3. Desativadores metálicos, por exemplo, N,N'-difeniloxamida, N-salicilal-N'-saliciloila hidrazina, N,N'-bis(saliciloil)hidrazina, N,N'-bis(3,5- di-terc-butil-4-hidroxifenilpropionil)hidrazina, 3-saliciloilamino-l,2,4-triazol, bis(benzilideno)oxalila diidrazida, oxanilida, isoftaloila diidrazida, sebacoila bisfenilidrazida, N,N'-diacetiladipoila diidrazida, N,N'-bis(saliciloil)oxalila diidrazida, N,N'-bis(saliciloil)tiopropionila diidrazida. 4. Fosfitos e fosfonitos, por exemplo, trifenil fosfito, difenilalquila fosfitos, fenildialquila fosfitos, tris(nonilfenil) fosfito, trilaurila fosfito, trioctadecila fosfito, distearilpentaeritritol difosfito, tris(2,4-di-terc- butilfenil) fosfito, diisodecila pentaeritritol difosfito, bis(2,4-di-terc- butilfenil)pentaeritritol difosfito, bis(2,4-di-cumilfenil)pentaeritritol difosfito, bis(2,6-di-terc-butil-4-metilfenil)pentaeritritol difosfito, diisodeciloxipentaeritritol difosfito, bis(2,4-di-terc-butil-6- metilfenil)pentaeritritol difosfito, bis(2,4,6-tris(terc-butilfenil)pentaeritritol difosfito, tristearila sorbitol trifosfito, tetraquis(2,4-di-terc-butilfenil) 4,4'- bifenileno difosfonito, 6-iso-octilóxi-2,4,8,10-tetra-terc-butil-12H- dibenz[d,g]-l,3,2-dioxafosfocin, bis(2,4-di-terc-butil-6-metilfenil)metil fosfito, bis(2,4-di-terc-butil-6-metilfenil)etil fosfito, 6-fluoro-2,4,8,10-tetra- terc-butil-12-metil-dibenz[d,g]-1,3,2-dioxafosfocin, 2,2',2"-nitrilo- [trietiltris(3,3',5,5'-tetra-terc-butil-l ,r-bifenil-2,2'-diil)fosfito], 2-etilexil- (3,3',5,5'-tetra-terc-butil-l, 1 '-bifenil-2,2'-diil)fosfito, 5-butil-5-etil-2-(2,4,6-tri- terc-butilphenóxi)-l,3,2-dioxafosfirano.[92] Still an additive can be selected from the following list: 1. Antioxidants 1.1. Alkylated monophenols, for example, 2,6-di-tert-butyl-4-methylphenol, 2-tert-butyl-4,6-dimethylphenol, 2,6-di-tert-butyl-4-ethylphenol, 2,6- di-tert-butyl-4-n-butylphenol, 2,6-di-tert-butyl-4-isobutylphenol, 2,6-dicyclopentyl-4-methylphenol, 2- (a-methylcyclohexyl) -4,6-dimethylphenol, 2,6-dioctadecyl-4-methylphenol, 2,4,6-tricyclohexylphenol, 2,6-di-tert-butyl-4-methoxymethylphenol, nonylphenols that are linear or branched in the secondary chains, for example, 2,6-di - nonyl-4-methylphenol, 2,4-dimethyl-6- (l'-methylundec-l'-yl) phenol, 2,4-dimethyl-6- (l'-methylpentadec-l'-yl) phenol, 2 , 4-dimethyl-6- (l'-methyltridec-1 '-yljphenol, 2,4-dimethyl-6- (l'-methyl-r-tetradecyl-methyl) -phenol and mixtures thereof. 1.2. Alkylthiomethylphenols, for example example, 2,4-dioctyltomethyl-6-tert-butylphenol, 2,4-dioctyltomethyl-6-methylphenol, 2,4-dioctyltomethyl-6-ethylphenol, 2,6-di-dodecylthiomethyl-4-nonylphenol 1.3. alkylated hydroquinones, for example, 2,6-di-tert-butyl-4-methoxyphenol, 2,5-di-tert-butylhydroquinone, 2,5-di-tert- amylhydroquinone, 2,6-diphenyl-4-octadecyloxyphenol, 2,6-di-tert-butylhydroquinone, 2,5-di-tert-butyl-4-hydroxyanisole, 3,5-di-tert-butyl-4-hydroxyanisole, 3,5-di-tert-butyl-4-hydroxyphenyl stearate, bis (3,5-di-tert-butyl-4-hydroxyphenyl) adipate. 1.4. Tocopherols, for example, oc-tocopherol, β-tocopherol, y-tocopherol, δ-tocopherol and mixtures thereof (vitamin E). 1.5. Hydroxylated thiodiphenyl ethers, for example, 2,2'-thiobis (6-tert-butyl-4-methylphenol), 2,2'-thiobis (4-octylphenol), 4,4'-thiobis (6-tert-butyl- 3-methylphenol), 4,4'-thiobis (6-tert-butyl-2-methylphenol), 4,4'-thiobis (3,6-di-sec-amylphenol), 4,4'-bis (2, 6-dimethyl-4-hydroxyphenyl) disulfide. 1.6. Alkylidanobisphenols, for example, 2,2'-methylenebis (6-tert-butyl-4-methylphenol), 2,2'-methylenebis (6-tert-butyl-4-ethylphenol), 2,2'-methylenebis [4- methyl-6- (oc-methylcyclohexyl) phenol], 2,2'-methylenebis (4-methyl-6-cyclohexylphenol), 2,2'-methylenebis (6-nonyl-4-methylphenol), 2,2'-methylenebis (4,6-di-tert-butylphenol), 2,2'-ethylidanobis (4,6-di-tert-butylphenol), 2,2'-ethylidanobis (6- tert-butyl-4-isobutylphenol), 2, 2'-methylenebis [6- (oc-methylbenzyl) -4-nonylphenol], 2,2'-methylenobis [6- (oc, oc-dimethylbenzyl) -4-nonylphenol], 4,4'-methylenebis (2,6 -di- tert-butylphenol), 4,4'-methylenebis (6-tert-butyl-2-methylphenol), 1,1-bis (5-tert-butyl-4-hydroxy-2-methylphenyl) butane, 2, 6-bis (3-tert-butyl-5-methyl-2-hydroxybenzyl) -4-methylphenol, 1,1,3-tris (5-tert-butyl-4-hydroxy-2-methylphenyl) butane, 1,1 -bis (5-tert-butyl-4-hydroxy-2-methylphenyl) -3-n-dodecylmercaptobutane, bis [3,3-bis (3'-tert-butyl-4'-hydroxyphenyl) ethylene glycol], bis (3-tert-butyl-4-hydroxy-5-methyl-phenyl) dicyclopentadiene, bis [2- (3'-tert-butyl-2'-h idroxy-5'-methylbenzyl) -6-tert-butyl-4-methylphenyl] terephthalate, 1,1-bis- (3,5-dimethyl-2-hydroxyphenyl) butane, 2,2-bis (3,5-di -tert-butyl-4-hydroxyphenyl) propane, 2,2-bis- (5-tert-butyl-4-hydroxy-2-methylphenyl) -4-n-dodecylmercaptobutane, 1,1,5,5-tetra (5 -tert-butyl-4-hydroxy-2-methylphenyl) pentane. 1.7. O-, N- and S-benzyl compounds, for example, 3,5,3 ', 5'-tetra-tert-butyl-4,4'-dihydroxydibenzyl ether, octadecyl-4-hydroxy-3,5 - dimethylbenzylmercaptoacetate, tridecyl-4-hydroxy-3,5-di-tert-butylbenzylmercaptoacetate, tris (3,5-di-tert-butyl-4-hydroxybenzyl) amine, bis (4-tert-butyl-3-hydroxy-2 , 6-dimethylbenzyl) dithiotherephthalate, bis (3,5-di-tert-butyl-4-hydroxybenzyl) sulfide, isooctyl-3,5-di-tert-butyl-4-hydroxybenzyl-mercaptoacetate. 1.8. Hydroxybenzylated malonates, for example, dioctadecyl-2,2-bis (3,5-di-tert-butyl-2-hydroxybenzyl) malonate, di-octadecyl-2- (3-tert-butyl-4-hydroxy-5- methylbenzyl) malonate, di-dodecylmercaptoethyl-2,2-bis (3,5-di-tert-butyl-4-hydroxybenzyl) malonate, bis [4- (1,1,3,3-tetramethylbutyl) phenyl] -2, 2- bis (3,5-di-tert-butyl-4-hydroxybenzyl) malonate. 1.9. Aromatic hydroxybenzyl compounds, for example, 1,3,5-tris (3,5-di-tert-butyl-4-hydroxybenzyl) -2,4,6-trimethylbenzene, 1,4-bis (3,5-di -tert-butyl-4-hydroxybenzyl) -2,3,5,6-tetramethylbenzene, 2,4,6-tris (3,5-di-tert-butyl-4-hydroxybenzyl) phenol. 1.10. Triazine compounds, for example, 2,4-bis (octylmercapto) -6- (3,5-di-tert-butyl-4-hydroxyanilino) -1, 3,5-triazine, 2-octylmercapto-4,6- bis (3,5-di-tert-butyl-4-hydroxyanilino) -1, 3,5-triazine, 2-octylmercapto-4,6-bis (3,5-di-tert-butyl-4-hydroxyphenoxy) - 1,3,5-triazine, 2,4,6-tris (3,5-di-tert-butyl-4-hydroxyphenoxy) -1, 2,3-triazine, 1,3,5-tris (3,5 -di-tert-butyl-4-hydroxybenzyl) isocyanurate, 1,3,5-tris (4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) isocyanurate, 2,4,6-tris (3,5 -di-tert-butyl-4-hydroxyphenylethyl) - 1,3,5-triazine, 1,3,5-tris (3,5-di-tert-butyl-4-hydroxyphenylpropionyl) -hexahydro- 1,3,5 -triazine, 1,3,5-tris (3,5-dicyclohexyl-4-hydroxybenzyl) isocyanurate. 1.11. Benzylphosphonates, for example, dimethyl-2,5-di-tert-butyl-4-hydroxybenzylphosphonate, diethyl-3,5-di-tert-butyl-4-hydroxybenzylphosphonate, dioctadecyl-3,5-di-tert-butyl-4 -hydroxybenzylphosphonate, dioctadecyl-5-tert-butyl-4-hydroxy-3-methylbenzylphosphonate, the calcium salt of 3,5-di-tert-butyl-4-hydroxybenzylphosphonic acid monoethyl ester. 1.12. Acylaminophenols, for example, 4-hydroxyluranilide, 4-hydroxystearanilide, octyl N- (3,5-di-tert-butyl-4-hydroxyphenyl) carbamate. 1.13. Esters of β- (3,5-di-tert-butyl-4-hydroxyphenyl) propionic acid with mono- or polyhydric alcohols, for example, with methanol, ethanol, n-octanol, i-octanol, octadecanol, a mixture of alkanol C13-C15 linear and branched, 1,6-hexanediol, 1,9-nonanediol, ethylene glycol, 1,2-propanediol, neopentyl glycol, thiodiethylene glycol, diethylene glycol, triethylene glycol, pentaerythritol, tris (hydroxyethyl) isocyanurate, N, N'-bis- (hydroxyl-ethyl) oxamide, 3-thiaundecanol, 3-thiapentadecanol, trimethylexanediol, trimethylolpropane, 4-hydroxymethyl-1-phosphate-2,6,7-trioxabicyclo [2.2.2] octane. 1.14. Esters of β- (5-tert-butyl-4-hydroxy-3-methylphenyl) propionic acid with mono- or polyhydric alcohols, for example, with methanol, ethanol, n-octanol, i-octanol, octadecanol, 1,6- hexanediol, 1,9-nonanediol, ethylene glycol, 1,2-propanediol, neopentyl glycol, thiodiethylene glycol, diethylene glycol, triethylene glycol, pentaerythritol, tris- (hydroxyethyl) isocyanurate, N, N'-bis (hydroxyethyl) oxamide, 3 -thiaundecanol, 3-thiapentadecanol, trimethylexanediol, trimethylolpropane, 4-hydroxymethyl-1-phosphate-2,6,7-trioxabicyclo [2.2.2] octane; 3,9-bis [2- {3- (3-tert-butyl-4-hydroxy-5-methyl-phenyl) propionyloxy} -1,1-dimethylethyl] -2,4,8,10-tetraoxaspiro [5.5] undecane. 1.15. Esters of β- (3,5-dicyclohexyl-4-hydroxyphenyl) propionic acid with mono- or polyhydric alcohols, for example, with methanol, ethanol, octanol, octadecanol, 1,6-hexanediol, 1,9-nonanediol, ethylene glycol , 1,2-propanediol, neopentyl glycol, thiodiethylene glycol, diethylene glycol, triethylene glycol, pentaerythritol, tris (hydroxyethyl) isocyanurate, N, N'-bis (hydroxyethyl) oxamide, 3-thiaundecanol, 3-thiapentadecanol, trimethylexanodiol, trimethylexanodiol, trimetylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol, trimethylexanodiol. 4-hydroxymethyl-1-phosphate-2,6,7-trioxabicyclo [2.2.2] octane. 1.16. Esters of 3,5-di-tert-butyl-4-hydroxyphenyl acetic acid with mono- or polyhydric alcohols, for example, with methanol, ethanol, octanol, octadecanol, 1,6-hexanediol, 1,9-nonanediol, ethylene glycol , 1,2-propanediol, neopentyl glycol, thiodiethylene glycol, diethylene glycol, triethylene glycol, pentaerythritol, tris (hydroxyethyl) isocyanurate, N, N'-bis (hydroxyethyl) oxamide, 3-thiaundecanol, 3-thiapentadecanol, trimethylexanodiol, trimethylexanpropiol, trimetylexanpropiol 4-hydroxymethyl-1-phosphate-2,6,7-trioxabicyclo [2.2.2] octane. 1.17. Β- (3,5-di-tert-butyl-4-hydroxyphenyl) propionic acid amides, for example, N, N'-bis (3,5-di-tert-butyl-4-hydroxyphenylpropionyl) hexamethylenediamide, N, N'-bis (3,5-di-tert-butyl-4-hydroxyphenylpropionyl) trimethylenediamide, N, N'-bis (3,5-di-tert-butyl-4-hydroxyphenylpropionyl) hydrazide, N, N'-bis [2- (3- [3,5-di-tert-butyl-4-hydroxyphenyl] propionyloxy) ethyl] oxamide (Naugard XL-1 (RTM), supplied by Uniroyal). 1.18. ascorbic acid (vitamin C) 1.19. Amino antioxidants, for example, N, N'-diisopropyl-p-phenylenediamine, N, N'-di-sec-butyl-p-phenylenediamine, N, N'-bis (1,4-dimethylpentyl) -p- phenylenediamine, N, N'-bis (1-ethyl-3-methylpentyl) -p-phenylenediamine, N, N'-bis (1-methylptyl) -p-phenylenediamine, N, N'-dicyclohexyl-p-phenylenediamine, N , N'-diphenyl-p-phenylenediamine, N, N'-bis (2-naptyl) -p-phenylenediamine, N-isopropyl-N'-phenyl-p-phenylenediamine, N- (1,3-dimethylbutyl) -N '-phenyl-p-phenylenediamine, N- (1-methylptyl) -N'-phenyl-p-phenylenediamine, N-cyclohexyl-N'-phenyl-p-phenylenediamine, 4- (p-toluenesulfamyl) diphenylamine, N , N'-dimethyl-N, N'-di-sec-butyl-p-phenylenediamine, diphenylamine, N-allyldiphenylamine, 4-isopropoxydiphenylamine, N-phenyl-1-naptilamine, N- (4-tert-octylphenyl) -l -naptilamine, N-phenyl-2-naptilamine, octylate diphenylamine, for example, p, p'-di-tert-octyldiphenylamine, 4-n-butylaminophenol, 4-butyrylaminophenol, 4-nonanoylaminophenol, 4-dodecanoylaminophenol, 4-octadecanil, 4-octadecanyl bis (4-methoxyphenyl) amine, 2,6-di-tert-butyl-4 -dimethylaminomethylphenol, 2,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylmethane, N, N, N ', N'-tetramethyl-4,4'-diaminodiphenylmethane, 1,2- bis [(2-methylphenyl) amino] ethane , 1,2-bis (phenylamino) propane, (o-tolyl) biguanide, bis [4- (l ', 3'-dimethylbutyl) phenyl] amine, tert-octylate N-phenyl-l-naptilamine, a mixture of tert -butyl / tert-octyldiphenylamines mono- and dialkylated, a mixture of mono- and dialkylated nonildiphenylamines, a mixture of mono- and dialkylated dodecyldiphenylamines, a mixture of mono- and dialkylated isopropyl / isohydrylphenylamines, a mixture of tert-butyl monohydrylines - and dialkylated, 2,3-dihydro-3,3-dimethyl-4H-1,4, 4-benzothiazine, phenothiazine, a mixture of mono- and dialkylated tert-butyl / tert-octylphenothiazines, a mixture of mono tert-octylphenothiazines - and dialkylated, N-allylphenothiazine, N, N, N ', N'-tetrafenyl-1,4-diaminobut-2-ene, N, N-bis (2,2,6,6-tetramethylpiperid-4-yl- hexamethylenediamine, bis (2,2,6,6-tetramethylpiperid-4-yl) sebacate, 2,2,6,6-tetramethylpiperidin -4-one, 2,2,6,6-tetramethylpiperidin-4-ol. 2. UV absorbers and light stabilizers 2.1. 2- (2'-Hydroxyphenyl) benzotriazoles, for example 2- (2'-hydroxy-5'-methylphenyl) benzotriazole, 2- (3 ', 5'-di-tert-butyl-2'-hydroxyphenyl) benzotriazole, 2- (5'-tert-butyl-2'-hydroxyphenyl) benzotriazole, 2- (2'-hydroxy-5 '- (1,1,3,3-tetramethylbutyl) phenyl) benzotriazole, 2- (3', 5 '-di-tert-butyl-2'-hydroxyphenyl) -5-chlorobenzotriazole, 2- (3'-tert-butyl-2'-hydroxy-5'-methylphenyl) -5-chlorobenzotriazole, 2- (3'-sec -butyl-5'-tert-butyl-2'-hydroxyphenyl) benzotriazole, 2- (2'-hydroxy-4'-octyloxyphenyl) benzotriazole, 2- (3 ', 5'-di-tert-amyl-2'- hydroxyphenyl) benzotriazole, 2- (3 ', 5'-bis (oc, CX-dimethylbenzyl) -2'-hydroxy-phenyl) benzotriazole, 2- (3'-tert-butyl-2'-hydroxy-5' - ( 2-octyloxycarbonylethyl) phenyl) - 5-chlorobenzotriazole, 2- (3'-tert-butyl-5 '- [2- (2-ethylhexyloxy) carbonylethyl] -2'-hydroxyphenyl) -5-chlorobenzotriazole, 2- (3'-tert-butyl-2'-hydroxy-5'- (2-methoxycarbonylethyl) phenyl) -5-chlorobenzotriazole, 2- (3'-tert-butyl-2'-hydroxy-5' - (2-methoxycarbonylethyl) phenyl) benzotriazole, 2- (3'-tert-butyl-2'-hydroxy-5 '- (2-octyloxycarbonylethyl) phenyl) b enzotriazole, 2- (3'-tert-butyl-5 '- [2- (2-ethylhexoxy) carbonylethyl] -2'-hydroxyphenyl) benzotriazole, 2- (3'-dodecyl-2'-hydroxy-5'-methylphenyl ) benzotriazole, 2- (3'-tert-butyl-2'-hydroxy-5 '- (2-isooctyloxycarbonylethyl) phenylbenzotriazole, 2,2'-methylenebis [4- (l, 1,3,3-tetramethylbutyl) -6-benzotriazol-2-ylphenol]; the trans-esterification product of 2- [3'-tert-butyl-5 '- (2-methoxycarbonylethyl) -2'-hydroxyphenyl] -2H-benzotriazole with polyethylene glycol 300;

where R '= 3'-tert-butyl-4'-hydroxy-5'-2H-benzotriazol-2-ylphenyl, 2- [2'-hydroxy-3' - (oc, oc-dimethylbenzyl) -5 '- ( 1,1,3,3-tetramethylbutyl) phenyl] benzotriazole; 2- [2'- hydroxy-3 '- (1,1,3,3-tetramethylbutyl) -5' - (oc, oc-dimethylbenzyl) phenyl] benzotriazole. 2.2. 2-Hydroxybenzophenones, for example, derivatives of 4-hydroxy, 4-methoxy, 4-octyloxy, 4-decyloxy, 4-dodecyloxy, 4-benzyloxy, 4,2 ', 4'-trihydroxy and 2'-hydroxy-4 , 4'-dimethoxy. 2.3. Substituted and unsubstituted benzoic acid esters, for example, 4-tert-butylphenyl salicylate, phenyl salicylate, octylphenyl salicylate, dibenzoyl resorcinol, bis (4-tert-butyl benzoyl) resorcinol, benzoyl resorcinol, 3,5-di-resorcinol 2,4-di-tert-butylphenyl tert-butyl-4-hydroxybenzoate, hexadecyl 3,5-di-tert-butyl-4-hydroxybenzoate, octadecyl 3,5-di-tert-butyl-4-hydroxybenzoate, 2-methyl-4,6-di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate. 2.4. Acrylates, for example, ethyl oc-cyano-β, β-diphenylacrylate, iso-octyl oc-cyano-β, methyl β-diphenylacrylate, methyl oc-carbomethoxycinnamate, methyl oc-cyano-β-methyl-p-methoxycinnamate , butyl α-cyano-β-methyl-p-methoxycinnamate, methyl oc-carbomethoxy-p-methoxycinnamate, N- (β-carbomet0xi-β-cyanovinyl) -2-methylindoline and neopentyl tetra (oc-cyano-β, β-diphenylacrylate). 2.5. Nickel compounds, for example, 2,2'-thiobis [4- (1,1,3,3-tetramethylbutyl) phenol] nickel complexes, such as the 1: 1 or 1: 2 complex, with or without ligands such as n-butylamine, triethanolamine or N-cyclohexyliethanolamine, nickel dibutyldithiocarbamate, nickel salts of monoalkyl esters, for example, methyl or ethyl ester, of 4-hydroxy-3,5-di-tert-butylbenzylphosphonic acid, complexes nickel from cetoximes, for example, 2-hydroxy-4-methylphenylundecylketoxime, nickel complexes from l-phenyl-4-lauroyl-5-hydroxypyrazole, with or without additional ligands. 2.6. Sterically hindered amines, for example, bis (2,2,6,6-tetramethyl-4-piperidyl) sebacate, bis (2,2,6,6-tetramethyl-4-piperidyl) succinate, bis (1,2,2 , 6,6-pentamethyl-4-piperidyl) sebacate, bis (1,2,2,6,6-pentamethyl-4-piperidyl) n-butyl-3,5-di-tert-butyl-4-hydroxybenzylmalonate, o condensate of l- (2-hydroxyethyl) -2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, linear or cyclic condensates of N, N'-bis (2,2,6,6-tetramethyl-4 -piperidyl) hexamethylenediamine and 4-tert-octylamino-2,6-dichloro-1,3,5-triazine, tris (2,2,6,6-tetramethyl-4-piperidyl) nitrilotriacetate, tetrakis (2,2,6 , 6-tetramethyl-4-piperidyl) -1,2,3,4-butanetetracarboxylate, 1,1'- (1,2-ethanediyl) -bis (3,3,5,5-tetramethylpiperazinone), 4-benzoyl- 2,2,6,6- tetramethylpiperidine, 4-stearyloxy-2,2,6,6-tetramethylpiperidine, bis (1,2,2,6,6-pentamethylpiperidyl) -2-n-butyl-2- (2- hydroxy-3,5-di-tert-butylbenzyl) malonate, 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro [4.5] decane-2,4-dione, bis ( l - octyloxy-2,2,6,6-tetramethylpiperid-4-yl) sebacate, bis (l-octyloxy-2,2,6,6-tetramethylpiperid-4-yl) succinate, bis- [2,2,6,6-tetramethyl-l- (undecyloxy) - piperidin-4-yl] carbonate , linear or cyclic condensates of N, N'-bis (2,2,6,6-tetramethyl-4-piperidyl) -hexamethylenediamine and 4-morpholino-2,6-dichloro-1,3,5-triazine, the condensate of 2-chloro-4,6-bis (4-n-butylamino- 2,2,6,6-tetramethylpiperidyl) -1,3,5-triazine and 1,2-bis (3-aminopropylamino) ethane, the condensate of 2-chloro-4,6-di- (4-n-butylamino-1,2,2,6,6-pentamethylpiperidyl) -1,5,5-triazine el, 2-bis (3-aminopropyl-amino) ethane, 8-acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro [4.5] decane-2,4-dione, 3-dodecyl-l- (2,2,6 , 6-tetramethyl-4-piperidyl) pyrrolidine-2,5-dione, 3-dodecyl-1- (1,2,2,6,6-pentamethyl-4-piperidyl) pyrrolidine-2,5-dione, a mixture of 4-hexadecyloxy- and 4-stearyloxy-2,2,6,6-tetramethylpiperidine, a condensate of N, N'-bis (2,2,6,6-tetramethyl-4-piperidyl) hexamethylenediamine and 4-cyclohexylamino- 2,6-dichloro-1,3,5-triazine, a 1,2-bis (3-aminopropylamino) condensate and tane and 2,4,6-trichloro-1,3,5-triazine as well as 4-butylamino-2,2,6,6-tetramethylpiperidine (CAS Reg. [136504-96-6]); a condensate of 1,6-hexanediamine and 2,4,6-trichloro-1,3,5-triazine as well as N, N-dibutylamine and 4-butylamino-2,2,6,6-tetramethylpiperidine (CAS Reg. N [192268 64-7]); N- (2,2,6,6-tetramethyl-4-piperidyl) -n-dodecyl succinimide, N- (1,2,2,6,6-pentamethyl-4-piperidyl) -n-dodecyl succinimide, 2-undecyl- 7,7,9,9- tetramethyl-l-oxa-3,8-diaza-4-oxo-spiro [4,5] decane, a reaction product of 7,7,9,9-tetramethyl-2-cycloundecyl -1 -oxa-3,8-diaza-4-oxospiro- [4,5] decane and epichlorohydrin, 1,1-bis (1,2,2,6,6-pentamethyl-4-piperidyloxycarbonyl) -2- ( 4-methoxyphenyl) -ethene, N, N'-bis-formyl-N, N'-bis (2,2,6,6-tetramethyl-4-piperidyl) hexamethylenediamine, a diester of 4-methoxymethylenemalonic acid with 1.2 , 2,6,6-pentamethyl-4-hydroxy-piperidine, poly [methylpropyl-3-oxy-4- (2,2,6,6-tetramethyl-4-piperidyl)] siloxane, a maleic acid reaction product of the anhydride-oc-olefin copolymer with 2,2,6,6-tetramethyl-4-aminopiperidine or 1,2,6,6-pentamethyl-4-aminopiperidine, a mixture of oligomeric compounds which are the condensation products formaldehyde of N, N'-bis- (2,2,6,6-tetramethyl-1-propoxy-piperidin-4-yl) -hexane-1,6-diamine and 2,4-dichloro-6- {n- butyl- (2,2,6,6-tetramethyl-1-propox i-piperidin-4-yl) - amino] - [1, 3,5] triazine and final coated with 2-chloro-4,6-bis- (di-n-butylamino) - [1, 3,5] triazine , a mixture of oligomeric compounds which are the formal condensation products of N, N'-bis- (2,2,6,6-tetramethyl-piperidin-4-yl) -hexane-1,6-diamine and 2,4 -dichloro-6- {n-butyl- (2,2,6,6-tetramethyl-piperidin-4-yl) -amino] - [1,5,5] triazine coated with 2-chloro-4,6- bis- (di- n-butylamino) - [1,3,5] triazine, 2,4-bis [N- (1-cyclohexyloxy-2,2,6,6-tetramethylpiperidine-4-yl) -N-butylamino ] -6- (2-hydroxyethyl) amino-1,3,5-triazine, 1- (2-hydroxy-2-methylpropoxy) -4-octadecanoyloxy-2,2,6,6-tetramethylpiperidine, 5- (2- ethylexanoyl) oxymethyl-3,3,5-trimethyl-2-morpholinone, Sanduvor (Clariant; CAS Reg. 106917-31-1], 5- (2-ethylexanoyl) -oxymethyl-3,3,5-trimethyl-2-morpholinone, the reaction product of 2,4-bis - [(1-cyclohexyloxy-2, 2,6,6-piperidine-4-yl) butylamino] -6-chloro-s-triazine with N, N'-bis- (3-amino-propyl) ethylenediamine), 1, 3,5-tris (N- cyclohexyl-N- (2,2,6,6-tetramethyl-piperazine-3-one-4-yl) amino) -s-triazine, 1,3,5-tris (N-cyclohexyl-N- (1,2 , 2,6,6-pentamethylpiperazine-3-one-4-yl) -amino) -s-triazine. 2.7. Oxamides, for example, 4,4'-dioctyloxyanilide, 2,2'-dietoxoxanilide, 2,2'-dioctyloxy-5,5'-di-tert-butoxanilide, 2,2'-didodecyloxy-5,5 '-di -tert-butoxanilide, 2-ethoxy-2'-ethyloxanilide, N, N'-bis (3-dimethylaminopropyl) oxamide, 2-ethoxy-5-tert-butyl-2'-ethoxyanilide and its mixture with 2-ethoxy-2 '-ethyl-5,4'-di-tert-butoxanilide, mixtures of oxanilides disubstituted by o- and p-methoxy and mixtures of oxanilides disubstituted by o- and p-ethoxy. 2.8. 2- (2-Hydroxyphenyl) -1, 3,5-triazines, for example, 2,4,6- tris (2-hydroxy-4-octyloxyphenyl) -1, 3,5-triazine, 2- (2-hydroxy -4-octyloxyphenyl) -4,6-bis (2,4-dimethylphenyl) -1, 3,5-triazine, 2- (2,4-dihydroxyphenyl) -4,6-bis (2,4-dimethylphenyl) ) -1, 3,5-triazine, 2,4-bis (2-hydroxy-4-propyloxyphenyl) -6- (2,4-dimethylphenyl) -1, 3,5-triazine, 2- (2-hydroxy- 4-octyloxyphenyl) -4,6-bis (4-methylphenyl) - 1,3,5-triazine, 2- (2-hydroxy-4-dodecyloxyphenyl) -4,6-bis (2,4-dimethylphenyl) -l , 3,5-triazine, 2- (2-hydroxy-4-tridecyloxyphenyl) -4,6-bis (2,4-dimethylphenyl) -1,3,5-triazine, 2- [2-hydroxy-4- ( 2-hydroxy-3-butyloxypropoxy) phenyl] -4,6-bis (2,4-dimethyl) -1, 3,5-triazine, 2- [2-hydroxy-4- (2-hydroxy-3-octyloxypropyloxy) phenyl] - 4,6-bis (2,4-dimethyl) -1,3,5-triazine, 2- [4- (dodecyloxy / tridecyloxy-2-hydroxypropoxy) -2-hydroxyphenyl] -4,6-bis ( 2,4-dimethylphenyl) -1,3,5-triazine, 2- [2-hydroxy-4- (2-hydroxy-3-dodecyloxypropoxy) phenyl] -4,6-bis (2,4-dimethylphenyl) - 1 , 3,5-triazine, 2- (2-hydroxy-4-hexyloxy) phenyl-4,6-diphenyl-1,5,5-triazine, 2- (2- hydroxy-4-m ethoxyphenyl) -4,6-diphenyl-1,3,5-triazine, 2,4,6-tris [2-hydroxy-4- (3 - butoxy-2-hydroxypropoxy) phenyl] -1,3,5-triazine , 2- (2-hydroxyphenyl) -4- (4-methoxyphenyl) -6-phenyl-1,3,5-triazine, 2- {2-hydroxy-4- [3 - (2-ethylexyl-1-oxy) -2-hydroxypropyloxy] phenyl} -4,6-bis -> (2,4-dimethylphenyl) -1,3,5-triazine. 3. Metal deactivators, for example, N, N'-diphenyloxamide, N-salicylal-N'-salicyloyl hydrazine, N, N'-bis (salicyloyl) hydrazine, N, N'-bis (3,5-di-tert -butyl-4-hydroxyphenylpropionyl) hydrazine, 3-salicyloylamino-1,2,4-triazole, bis (benzylidene) oxalyl diidrazide, oxanilide, isophthaloyl diidrazide, sebacoyl bisphenylhydrazide, N, N'-diacetyladipoyl bisidrazide, N (salicyloyl) oxalyl diidrazide, N, N'-bis (salicyloyl) thiopropionyl diidrazide. 4. Phosphites and phosphonites, for example, triphenyl phosphite, diphenylalkyl phosphites, phenyldialkyl phosphites, tris (nonylphenyl) phosphite, trilauryl phosphite, trioctadecyl phosphite, distearylpentaerythritol diphosphite, tris (2,4-di-tertityl-di-tertitol) , bis (2,4-di-tert-butylphenyl) pentaerythritol diphosphite, bis (2,4-di-cumylphenyl) pentaerythritol diphosphite, bis (2,6-di-tert-butyl-4-methylphenyl) pentaerythritol diphosphite, diisodecyloxypentaerythritol diphosphite , bis (2,4-di-tert-butyl-6-methylphenyl) pentaerythritol diphosphite, bis (2,4,6-tris (tert-butylphenyl) pentaerythritol diphosphite, tristearyl sorbitol triphosphite, tetrakis (2,4-di-tert -butylphenyl) 4,4'- biphenylene diphosphonite, 6-isooctyloxy-2,4,8,10-tetra-tert-butyl-12H-dibenz [d, g] -1, 3,2-dioxafosfocin, bis ( 2,4-di-tert-butyl-6-methylphenyl) methyl phosphite, bis (2,4-di-tert-butyl-6-methylphenyl) ethyl phosphite, 6-fluoro-2,4,8,10-tetra- tert-butyl-12-methyl-dibenz [d, g] -1,3,2-dioxafosfocin, 2,2 ', 2 "-nitrile- [triethyltris (3,3', 5,5 '-tetra-tert-butyl-l, r-biphenyl-2,2'-diyl) phosphite], 2-ethylexyl- (3,3', 5,5'-tetra-tert-butyl-1,1 '- biphenyl-2,2'-diyl) phosphite, 5-butyl-5-ethyl-2- (2,4,6-tri-tert-butylphenoxy) -1,2,2-dioxaphosphyran.

5. Hidroxilaminas e N-óxidos de amina, por exemplo, N,N- dibenzilidroxilamina, N,N-dietilidroxilamina, N,N-dioctilidroxilamina, N,N- N,N-ditetradecilidroxilamina, N,N- N,N-dioctadecilidroxilamina, N-hexadecil-N- N-heptadecil-N-octadecilidroxilamina, N,N- dialquilidroxilamina derivado de amina de sebo hidrogenado ou N,N-bis- (alquila de óleo de colza hidrogenada)-N-metil-amina N-óxido. 6. Nitronas, por exemplo, N-benzil-alfa-fenilnitrona, N-etil- alfa-metilnitrona, N-octil-alfa-heptilnitrona, N-lauril-alfa-undecilnitrona, N- tetradecil-alfa-tridecilnitrona, N-hexadecil-alfa-pentadecilnitrona, N- octadecil-alfa-heptadecilnitrona, N-hexadecil-alfa-heptadecilnitrona, N- ocatadecil-alfa-pentadecilnitrona, N-heptadecil-alfa-heptadecilnitrona, N- octadecil-alfa-hexadecilnitrona, nitrona derivado de N,N-dialquilidroxilamina derivado de amina de sebo hidrogenado. 7. Tiossinergistas, por exemplo, dilaurila tiodipropionato, dimistrila tiodipropionato, distearila tiodipropionato e pentaeritritol tetraquis- [3-(n-lauril)-éster de ácido propiônico]. 8. Descontaminantes de peróxido, por exemplo, ésteres de ácido oc-tiodipropiônico, por exemplo, os lauril, estearil, miristil ou tridecil ésteres, mercaptobenzimidazol ou o sal de zinco de 2-mercaptobenzimidazol, zinco dibutilditiocarbamato, dioctadecila bissulfeto, pentaeritritol tetraquis(β- dodecilmercapto)propionato. 9. Estabilizadores de poliamida, por exemplo, sais de cobre em combinação com iodetos e/ou compostos de fósforo e sais de manganês bivalentes. 10. descontaminantes ácidos, por exemplo, melamina, polivinilpirrolidona, diciandiamida, trialil cianurato, derivados de uréia, derivados de hidrazina, aminas, poliamidas, poliuretanos, sais de metal alcalino e sais de metal alcalino terroso de ácidos graxos superiores, por exemplo, estearato de cálcio, estearato de zinco, beenato de magnésio, estearato de magnésio, ricinoleato de sódio e palmitato de potássio, pirocatecolato de antimônio e pirocatecolato de zinco. 11. Benzofuranonas e indolinonas, por exemplo, aquelas descrevedas em US-A-4,325,863; US A-4,338,244; US-A-5,175,312; US-A- 5,216,052; US-A-5,252,643; DE-A-4316611; DE-A-4316622; DE-A- 4316876; EP-A-0589839 ou EP-A-0591102 ou 3-[4-(2-acetoxietóxi)fenil]- 5,7-di-terc-butilbenzofuran-2-ona, 5,7-di-terc-butil-3-[4-(2-stearoiloxi- etóxi)fenil]benzofuran-2-ona, 3,3'-bis[5,7-di-terc-butil-3-(4-[2-hidroxietóxi]- fenil)benzofuran-2-one], 5,7-di-terc-butil-3-(4-etoxifenil)benzofuran-2-ona, 3-(4-acetóxi-3,5-dimetilfenil)-5,7-di-terc-butilbenzofuran-2-ona, 3-(3,5- dimetil-4-pivaloiloxifenil)-5,7-di-terc-butilbenzofuran-2-ona, 3-(3,4- dimetilfenil)-5,7-di-terc-butilbenzofuran-2-ona, 3-(2,3-dimetilfenil)-5,7-di- terc-butilbenzofuran-2-ona e 3-(2-acetóxi-4-(l ,1,3,3-tetrametil-butil)-fenil)-5- (1,1,3,3 -tetrametil-butil)-benzofuran-2-ona. 12. Agentes nucleadores, por exemplo, substâncias inorgânicas, tais como talco, óxidos metálicos, tais como dióxido de titânioou óxido de magnésio, fosfatos, carbonatos ou sulfatos de, preferivelmente, metais alcalinos terrosos; compostos orgânicos, tais como ácidos mono- ou policarboxílicos e seus sais, por exemplo, ácido 4-terc-butilbenzóico, ácido adípico, ácido difenilacético, succinato de sódio ou benzoato de sódio; compostos poliméricos, tais como copolímeros iônicos (ionômeros), Irgaclear XT 386 (RTM BASF), l,3:2,4-bis(3’,4’-dimetilbenzilideno)-sorbitol, 1,3:2,4- di(parametildibenzilideno)-sorbitol, e 1,3:2,4-di(benzilideno)sorbitol. 13. Enchedores e agentes de reforço, por exemplo, carbonato de cálcio, silicatos, fibras de vidro, pérolas de vidro, asbestos, talco, caulim, bentonita, mica, hidrotalcita, sulfato de bário, óxidos e hidróxidos metálicos, negro de fumo, grafita, farinha de madeira e farinhas ou fibras de outros produtos naturais, fibras sintéticas. 14. Outros aditivos, por exemplo, plasticizantes, lubrificantes, aditivos de reologia, catalisadores, agentes de controle de fluxo, abrilhantadores óticos, agentes à prova de chama, agentes anti-estáticos e agentes de sopro.[93] The following phosphites are especially preferred: Tris (2,4-di-tert-butylphenyl) phosphite (Irgafos 168, RTM BASF), tris (nonylphenyl) phosphite,

5. Hydroxylamines and N-oxides of amine, for example, N, N-dibenzylhydroxylamine, N, N-diethylhydroxylamine, N, N-dioctyhydroxylamine, N, N- N, N-ditetradecylhydroxylamine, N, N-N, N-dioctadecylhydroxylamine , N-hexadecyl-N- N-heptadecyl-N-octadecylhydroxylamine, N, N-dialkylhydroxylamine derived from hydrogenated tallow amine or N, N-bis- (hydrogenated rape oil alkyl) -N-methyl-amine N-oxide . 6. Nitrones, for example, N-benzyl-alpha-phenylnitrone, N-ethyl-alpha-methylnitrone, N-octyl-alpha-heptynitrone, N-lauryl-alpha-undecylnitrone, N-tetradecyl-alpha-tridecylnitrone, N-hexadecyl -alpha-pentadecylnitrone, N- octadecyl-alpha-heptadecylnitrone, N-hexadecyl-alpha-heptadecylnitrone, N-ocatadecyl-alpha-pentadecylnitrone, N-heptadecyl-alpha-heptadecylnitrone, N-octadyl-alpha-hexadecyl-nitrate N-dialkylhydroxylamine derived from hydrogenated tallow amine. 7. Thiosynergists, for example, dilauryl thiodipropionate, dimistryl thiodipropionate, distearyl thiodipropionate and pentaerythritol tetrakis- [3- (n-lauryl) -propionic acid ester]. 8. Peroxide decontaminants, for example, esters of oc-thiodipropionic acid, for example, lauryl, stearyl, myristyl or tridecyl esters, mercaptobenzimidazole or the zinc salt of 2-mercaptobenzimidazole, zinc dibutyldiocarbamate, dioctadityl, tetrahydrate - dodecylmercapto) propionate. 9. Polyamide stabilizers, for example, copper salts in combination with iodides and / or phosphorus compounds and divalent manganese salts. 10. acid decontaminants, for example, melamine, polyvinylpyrrolidone, diciandiamide, trialyl cyanurate, urea derivatives, hydrazine derivatives, amines, polyamides, polyurethanes, alkali metal salts and alkaline earth metal salts of higher fatty acids, for example stearate calcium, zinc stearate, magnesium beenate, magnesium stearate, sodium ricinoleate and potassium palmitate, antimony pyrocatecholate and zinc pyrocatecholate. 11. Benzofuranones and indolinones, for example, those described in US-A-4,325,863; US A-4,338,244; US-A-5,175,312; US-A- 5,216,052; US-A-5,252,643; DE-A-4316611; DE-A-4316622; DE-A-4316876; EP-A-0589839 or EP-A-0591102 or 3- [4- (2-acetoxyethoxy) phenyl] - 5,7-di-tert-butylbenzofuran-2-one, 5,7-di-tert-butyl-3 - [4- (2-stearoyloxy-ethoxy) phenyl] benzofuran-2-one, 3,3'-bis [5,7-di-tert-butyl-3- (4- [2-hydroxyethoxy] - phenyl) benzofuran -2-one], 5,7-di-tert-butyl-3- (4-ethoxyphenyl) benzofuran-2-one, 3- (4-acetoxy-3,5-dimethylphenyl) -5,7-di-tert -butylbenzofuran-2-one, 3- (3,5-dimethyl-4-pivaloyloxyphenyl) -5,7-di-tert-butylbenzofuran-2-one, 3- (3,4-dimethylphenyl) -5,7-di -tert-butylbenzofuran-2-one, 3- (2,3-dimethylphenyl) -5,7-di-tert-butylbenzofuran-2-one and 3- (2-acetoxy-4- (l, 1,3,3 -tetramethyl-butyl) -phenyl) -5- (1,1,3,3-tetramethyl-butyl) -benzofuran-2-one. 12. Nucleating agents, for example, inorganic substances, such as talc, metal oxides, such as titanium dioxide or magnesium oxide, phosphates, carbonates or sulfates of, preferably, alkaline earth metals; organic compounds, such as mono- or polycarboxylic acids and their salts, for example, 4-tert-butylbenzoic acid, adipic acid, diphenylacetic acid, sodium succinate or sodium benzoate; polymeric compounds, such as ionic copolymers (ionomers), Irgaclear XT 386 (RTM BASF), 1,3: 2,4-bis (3 ', 4'-dimethylbenzylidene) -sorbitol, 1,3: 2,4- di ( paramethyldibenzylidene) -sorbitol, and 1,3: 2,4-di (benzylidene) sorbitol. 13. Fillers and reinforcing agents, for example, calcium carbonate, silicates, glass fibers, glass beads, asbestos, talc, kaolin, bentonite, mica, hydrotalcite, barium sulfate, metal oxides and hydroxides, carbon black, graphite, wood flour and flours or fibers from other natural products, synthetic fibers. 14. Other additives, for example, plasticizers, lubricants, rheology additives, catalysts, flow control agents, optical brighteners, flameproof agents, antistatic agents and blowing agents.

[94] A composition is preferred, which comprises a component a), a component b) and as component c) an additional additive.

[95] A composition is preferred, in which the weight ratio of component b) to component c) is 10: 1 to 1: 30, in particular from 4: 1 to 1: 20, especially from 2: 1 to 1:10 and the total amount of component b) and component c) is below 50% by weight of component a).

[96] A composition is preferred, comprising component c) an additional additive selected from the group consisting of an antioxidant, a UV absorber, a light hindered amine stabilizer, a nickel compound, metal deactivator, a phosphite or phosphonite, a hydroxylamine or amine N-oxide, a thiosynergist, a peroxide decontaminant, a nucleating agent and a filler or reinforcing agent.

[97] A composition is preferred, comprising component c) an additional additive selected from the group consisting of a phosphite or phosphonite, an acid decontaminant, a phenolic antioxidant and an amino antioxidant.

[98] A composition is preferred, which comprises component c) a phenolic antioxidant.

[99] A composition is preferred, comprising component c) a phenolic antioxidant, which is an ester of β- (3,5-di-tert-butyl-4-hydroxyphenyl) propionic acid.

[100] Optionally, a composition comprising a component a), a component b) and a component c) contains as component d) an additional second additive.

[101] A composition is preferred, comprising a component a), a component b), as component c) an additional additive and as component d) an additional second additive.

[102] A composition is preferred, in which the weight ratio of component b) to component d) is 10: 1 to 1: 30, in particular from 4: 1 to 1: 20, especially from 2: 1 to 1:10 and where the total amount of component b), component c) and component d) is below 50% by weight of component a).

[103] A composition is preferred, which comprises a component a), a component b), as component c) an additional additive, which is selected from the group consisting of a phosphite or phosphonite, an acid decontaminant, a phenolic antioxidant and an amino antioxidant and as component d) an additional second additive.

[104] A composition is preferred, which comprises a component a), a component b), a component c) and a component d), wherein component c) and component d) are independently of each other a phosphite or phosphonite, an acidic decontaminant, a phenolic antioxidant or an amino antioxidant.

[105] A composition is preferred, which comprises a component a), a component b), as component c) a phenolic antioxidant and as component d) a phosphite or phosphonite.

[106] A composition is preferred, which comprises a component a), a component b), as component c) a phenolic antioxidant and as component d) an amino antioxidant.

[107] The preferences described above for a compound of formula I and an organic material susceptible to thermal degradation or induced by oxidative light also apply to the additional embodiments of the invention. This also applies to the other optional additive and the other optional second additive.

[108] A further embodiment of the invention relates to a process for the protection of an organic material susceptible to thermal degradation or induced by oxidative light, that is, component a), which comprises the step of incorporation in or application in an organic material, a compound of formula I, that is, component b).

[109] The incorporation or application of component b) can be carried out in a processing mechanism, in particular a heatable container equipped with a stirrer, which can preferably be closed. A heated container equipped with an agitator is, for example, a kneader, an extruder, mixer or agitated container. Specific examples of these are a single screw extruder, planetary gear counter-rotation and co-rotation twin screw extruder, ring extruder or co-kneader. It is also possible to use a processing mechanism, which contains at least one gas removal compartment to which a vacuum can be applied and / or which can be fixed under an atmosphere, in which the oxygen content is low or oxygen is absent . Component b) can be added directly to the processing engine.

[110] Component b) can be incorporated or applied to any processing stage of component a), in particular before or during a component forming operation a) in the processing mechanism.

[111] Component b) can be incorporated or applied in the form of a dry powder, in the form of a melt, in an encapsulated form, such as encapsulation in a wax or polymer or in the form of a wet mixture such as a solution, dispersion or suspension, for example, in an inert solvent, water or oil. A dispersing or suspending agent may be present in the case of a wet mixture of component b).

[112] Component b) can also be incorporated or applied by spraying on component a).

[113] In the case that component a) is a polymer, an additional possibility for the incorporation or application of component b) to component a) is adduction before, during or directly after the polymerization of the corresponding starting materials, for example, monomers , of component a). For example, spraying during deactivation of the polymerization catalysts is particularly advantageous. If crosslinking occurs during the formation of component a), incorporation or application before crosslinking is preferred.

[114] In case component a) is a polymer, the incorporation or application process is preferably a molding process, in particular, injection molding, blow molding, compression molding, roto-molding, molding by sludge or extrusion molding.

[115] A process is preferred, in which the incorporation or application takes place at a temperature in the range of 150 to 340 ° C, in particular from 180 ° C to 330 ° C, especially from 190 ° C to 320 ° C.

[116] A process is preferred, in which component b) is incorporated or applied in an extruder during the processing of component a).

[117] In the case of an additional additive, that is, component c) or components c) and d), component b) and the additional additive can be incorporated into or applied to component a) individually or mixed together. If desired, the individual components can be mixed with one another prior to incorporation into component a) for example, by dry combining, compacting, melting, encapsulating with a wax or polymer or as a wet mixture in the form of solutions, dispersions or suspensions, by example, in an inert solvent, water or oil.

[118] Component b) and an additional additive can also be added to component a) in the form of a main group ('concentrate'), which contains component b), an additional additive and a main group polymer. Component b) and an additional additive are incorporated into the main group in a concentration, for example, from 1% to 40% and, preferably 2% to 20% by weight of the main group. The content of the main group polymer is about 100% by weight of the main group. The polymer of the main group should not necessarily be the same as the polymer as component a) if the latter is a polymer.

[119] A further embodiment of the invention relates to an additive composition, which comprises b) a compound of formula I and c) an additional additive selected from the group consisting of a phosphite or phosphonite, an acid decontaminant, an antioxidant phenolic or an amino antioxidant.

[120] A composition is preferred, in which the weight ratio of component b) to component c) is 10: 1 to 1: 30, in particular from 4: 1 to 1: 20, especially from 2: 1 to 1:10.

[121] An additive composition is preferred, comprising component d) as an additional second additive.

[122] An additive composition is preferred, comprising b) a compound of formula I, c) an additional additive selected from the group consisting of a phosphite or phosphonite, an acid decontaminant, a phenolic antioxidant or an amino antioxidant and d) a second additional additive selected from a group consisting of a phosphite or phosphonite, an acid decontaminant, a phenolic antioxidant or an amino antioxidant.

[123] A composition is preferred, in which the weight ratio of component b) to component c) is 10: 1 to 1: 30, in particular from 4: 1 to 1: 20, especially from 2: 1 to 1: 10, and where the weight ratio of component b) to component d) is 10: 1 to 1: 30, in particular from 4: 1 to 1: 20, especially from 2: 1 to 1: 10.

[124] A further embodiment of the invention relates to an article, which is made from a composition comprising a) an organic material susceptible to thermal degradation or induced by oxidative light, which is a polymer and b) a compound of formula I.

[125] The composition can be advantageously used for the preparation of various formed articles. Examples for such an article are: 1-1) Floating devices, marine applications, pontoons, buoys, plastic wood for decks, piers, boats, kayaks, paddles and beach reinforcements. 1-2) Automotive applications, in particular bumpers, panels, batteries, rear and front linings, molded parts under the hood, hat shelves, trunk linings, interior linings, air bag covers, electronic frames for accessories (lights), panels, headlight glass, instrument panels, exterior trim, upholstery, automotive lights, headlights, parking lights, rear lights, parking lights, interior and exterior finishes, door panels, gas tank; front windows, rear windows; rear seats, exterior panels, wire insulation, extrusion of sealing profiles, cladding, support covers, chassis parts, exhaust systems, fuel filter / filler, fuel pumps, fuel tank, body side moldings, tops convertibles, exterior mirrors, exterior in good condition, screws / fixings, front end module, glass, hinges, locking systems, luggage / roof supports, compressed / stamped parts, seals, side impact protectors, damper / sound isolator and sunroof. 1-3) Road traffic devices, in particular, signposts, posts for road marking, automotive accessories, warning triangles, medical cases, helmets, tires. 1-4) devices for airplane, railroad, motor car (car, motorcycle, trucks) including accessories. 1-5) Devices for space applications, in particular rockets and satellites, for example, reentry shields. 1-6) Devices for architecture and projects, mining applications, acoustic soundproof systems, refuges and street shelters. II-l) Devices, boxes and covers in general and electrical / electronic devices (personal computer, telephone, portable phone, printer, television sets, audio and video devices), flower pots, satellite TV antennas and panel. II-2) Coatings for other materials, such as steel or textiles. II-3) Devices for the electronics industry, in particular insulation for connectors, especially computer connectors, boxes for electrical or electronic parts, printed plates and materials for storing electronic data such as chips, verification cards or credit cards. 11-4) Electrical devices, in particular washing machines, front entrance washers, ovens (microwave ovens), dish washers, mixers and irons. II-5) Light covers (for example, street lights, lamps). II-6) Applications in wires and cables (semiconductor, insulation and cable sheath). II-7) sheets for condensers, refrigerators, heating devices, air conditioners, electronics packaging, semiconductors, coffee machines and vacuum cleaners. III-1) Technical articles, such as racks (gears), sliding adjustments, spacers, screws, nuts, cranks and handles. III-2) Rotor blades, windmill fans and pinwheels, solar devices, swimming pools, pool covers, pool coverings, reservoir coverings, closets, wardrobes, partition walls, slat walls, folding walls, roofs, shutters (for example, roll shutters), adjustments, connections between tubes, connections, and conveyor belts. III-3) Sanitary articles, in particular, shower stalls, washbasin seats, covers and sinks. III-4) Hygienic articles, in particular diapers (babies, adult incontinence), feminine hygiene articles, shower curtains, brushes, carpet, bathtubs, mobile toilets, toothbrushes and bedpans. III-5) tubes (reticulated or not) for water, waste water or chemicals, tubes for the protection of wires and cables, tubes for gas, oil and sewage, gutters, drain pipes and drainage systems. III-6) Profiles of any geometry (windows) and sides. III-7) glass substitutes, in particular, extruded or coextruded plates, glazing for buildings (monolithic, twin or multi-wall), aircraft, schools, extruded sheets, window film for architectural glazing, train, transportation, sanitary ware and greenhouse. III-8) Plates (walls, cutting boards), extrusion coating (photo paper, tetrapack and pipe coating), silos, wood substitutes, plastic woods, wood composites, walls, surfaces, furniture, decorative sheets, coverings floors (indoor and outdoor applications), floors, mats and tiles. III-9) Inlet or outlet tubes. III-10) Applications of cement, concrete, composite and roofing, tile sides and coverings, handrails, kitchen countertops, roofs, roofing sheets, tiles and tarpaulins. IV-1) Plates (walls and cutting boards), trays, artificial grass, artificial covers for stadium rings (sports games), artificial floor for stadium rings (sports games) and ribbons. IV-2) Fabrics, continuous fabrics and wool fibers, fibers (carpets / hygienic articles / geotextiles / monofilaments, filters, scarves / curtains (bulkheads) / medical applications), bulk fibers (applications such as dress / protective clothing), hammocks , ropes, cables, twine, cords, threads, seat belts, clothing, underwear, gloves, boots, rubber boots, underwear, clothing, swimwear, sporting goods, umbrellas (sunshades, umbrellas sun), parachutes, glides, candles, “silk balloon”, camping goods, tents, air mattresses, sunbeds, bulk bags and handbags. Non-woven fabrics such as medical fabrics and related suits, industrial clothing, outer fabrics, home furniture and construction fabrics. IV-3) Membranes, insulation, roofing and sealers for roofs, tunnels, garbage dumps, reservoirs, membranes for covering walls, geomembranes, swimming pools, curtains (shades) / sunscreens, awnings, canopies, wallpaper, food packaging and wraps (flexible and solid), medical packaging (flexible and solid), airbag / seat belts, arm and leg rests, carpets, center console, panels, seats, door, upper console module, door decorations , ceiling coverings, interior lighting, interior mirrors, earplugs, rear luggage cover, seats, steering column, steering wheel, textiles and trunk decorations. V) Films (packaging, dumping, lamination, agriculture and horticulture, greenhouse, plant material, tunnel, silage), bales wrapping, swimming pools, waste bags, wallpaper, stretch film, raffia, slide film batteries and connectors . V I-1) Food packaging and wrapping (flexible and solid), bottles. V I-2) Storage systems, such as boxes (crates), luggage, chests, household boxes, pallets, shelves, rails, threaded boxes, packages and cans. V I-3) Cartridges, syringes, medical applications, containers for any transport, waste baskets and waste compartments, waste bags, compartments, dust compartments, compartment coverings, wheel compartments, containers in general, water tanks / used water / chemicals / gas / oil / gasoline / diesel; tank liners, boxes, crates, battery shells, bowls, medical devices such as pistons, ophthalmic applications, ophthalmic applications, diagnostic devices and packaging for pharmaceutical blister packaging. V II-1) Extrusion coating (photo paper, tetrapack, tube coating), household items of any kind (for example, devices, thermoses / clothes hangers), fastening systems such as connectors, wire clamps and cable, zippers, locks, locks and quick locks. V II-2) Support devices, items for leisure periods, such as devices for sport and convenience, gymnastics mats, ski boots, inline skates, skis, big foot, athletic surfaces (eg tennis courts) ; screw caps, caps and stoppers for bottles and cans. V II-3) Furniture in general, foam articles (pillows, shock absorbers), foams, sponges, tea towels, mats, garden chairs, stadium seats, tables, sofas, toys, construction kits (boards / figures / spheres), toy houses, slides and toy vehicles. V II-4) Materials for storing optical and magnetic data. V II-5) kitchen items (eating, drinking, cooking, storing). V II-6) Boxes for CDs, cassettes and video tapes; electronic DVD articles, office supplies of all kinds (ballpoint pens, ink stamps and pads, mouse, shelves, rails), bottles of any volume and content (drinks, detergents, cosmetics, including perfumes) and tapes adhesive. V II-7) Footwear (shoes / shoe soles), insoles, gaiters, adhesives, structural adhesives, food boxes (fruits, vegetables, meat, fish), synthetic paper, labels for bottles, sofas, artificial (human) joints , printing plates (flexographic), printed circuit boards and video technologies. V II-8) filled polymer devices (talc, chalk, Chinese clay (kaolin), wollastonite, pigments, carbon black, TiCE, mica, nanocomposites, dolomite, silicates, glass, asbestos).

[126] An article that is a film, tube, profile, bottle, container tank or fiber is preferred.

[127] An article, which is shaped, is preferred. In particular, molding is carried out by injection, blow, compression, roto-molding, slush molding or extrusion.

[128] A further embodiment of an invention relates to the use of a compound of formula I, i.e. component b), to stabilize an organic material susceptible to thermal degradation or induced by oxidative light, i.e. component a), against degradation by oxidation, heat or light.

[129] It is preferred to use component b) to stabilize the polyurethane foam against vulcanization.

[130] The processing of a component a) is characterized as short term exposure of component a) to heat, for example, at a temperature in the range of 150 ° C to 340 ° C, during the processing time of component a) . The processing time is short compared, for example, to the possible time of use. Use typically takes place at a temperature of, for example, 0 ° C to 50 ° C, which is below the temperature during processing.

[131] It is preferred to use component b) to stabilize component a) against thermal and oxidative degradation during processing.

[132] The compounds of formula I are partly new and partly known. Several synthetic routes known to compounds of formula I are described in the literature.

(I) em que quando n é 1 A é -C(=O)-OR’i, -C(=O)-N(R’2)(R’3) OU -SO2-fenila; quando n é 2 A é -C(=O)-O-Zi-O-C(=O)-, -C(=O)-N(R”I)-Z2-N(R”2)- C(=OJ- ou piperazino-N,N’-biscarbonila; quando n é 3 A é alcano Cj-Ci2 tri-(oxicarbonila), 3-etil-3-azapentano- 1,5,2’-tri-(oxicarbonila), 1,4,7-triazaeptano-l ,4,7-tricarbonila, 1,4,8- triazaoctano-1,4,8-tricarbonila ou 1,5,9-triazanonano-l ,5,9-tricarbonila; quando n é 4 A é alcano C4-C16 tetra-(oxicarbonila), 1,4,7,10- tetraazadecano-l,4,7,10-tetracarbonila, 1,4,8,1 l-tetraazaundecano-1,4,8,11- tetracarbonila ou 1,5,8,12-tetraazadodecano-1,5,8,12-tetracarbonila; n é 1, 2, 3 ou 4; Ri, R2, R3, R4, R5, RÓ, R7, Rs, R9 e Rio são independentemente um do outro H, alquila Ci-Cs, cicloalquila C4-C8, fenila, alcóxi C1-C4 ou halogênio; R’i é H, alquila Ci-C22, alquenila C2-Cis, alcino-ila Cs-Ci2, cicloalquila C4-C8, que é não substituído ou substituído por um a três alquila C1-C4, cicloalquila C4-Cs-alquila C1-C4, alquila Cs-C2o bicíclica ou tricíclica, arila Có-Cu-alquila C1-C4, alquila C2-Ci2, que é substituído por um ou mais grupos hidroxila, alquila C4-Ci2, que é interrompido por um ou mais átomos de oxigênio, alquila C4-C18, que é interrompido por um átomo de enxofre, 2,2,6,6-tetrametilpiperidino-4-ila, 1-(alquila Ci-Cs)-2,2,6,6- tetrametilpiperidino-4-ila ou 1-(alcóxi Ci-Ci8)-2,2,6,6-tetrametilpiperidino-4- ila; R’2 e R’3 são independentemente um do outro H, alquila Ci- C22, alquenila C2-Ci8, cicloalquila C4-C8, que é não substituído ou substituído por um a três alquila C1-C4, arila CÓ-CIO, cicloalquila C4-Cs-alquila C1-C4, arila Có-Cu-alquila C1-C4, alquila C2-C6, que é substituído por um grupo hidroxila, 2,2,6,6-tetrametilpiperidino-4-ila, 1-(alquila Ci-Cs)-2,2,6,6- tetrametilpiperidino-4-ila ou 1-(alcóxi Ci-Ci8)-2,2,6,6-tetrametilpiperidino-4- ila ou R’2 e R’3 forma, junto com o átomo de hidrogênio ao qual estes são ligados ao heterociclo saturado de 5, 6 ou 7 membros; R”i e R”2 são independentemente um do outro H, alquila Ci- C22, alquenila C2-C18, cicloalquila C4-C8, que é não substituído ou substituído por um a três alquila C1-C4, cicloalquila C4-C8-alquila C1-C4, arila C6-Ci4- alquila C1-C4; Zi é alquileno C2-C12, cicloalquileno C4-C8, cicloalcano C4-C8- bis-(alquileno C1-C4), areno CÓ-CU bis-(alquileno C1-C4), alquileno C3-C6, que é substituído por um ou mais grupos hidroxila, alquileno C4-C12, que é interrompido por um ou mais átomos de oxigênio, hexaidro-furo[3,2- b]furano-3,6-diila, alquileno C4-C8, que é interrompido por um átomo de enxofre, 3-(alquila Ci-C8)-3-azapentano-l,5-diila, 4-(alquila CI-C8)-4- azaeptano-l,7-diila ou l-etil-2,2,6,6-tetrametilpiperidino-4,2’-diila e Z2 é alquileno C2-C12, cicloalquileno C4-C8, arileno CÓ-CH, cicloalcano C4-C8-bis(alquileno C1-C4), areno CÓ-CU bis-(alquileno C1-C4), alquileno C4-C12, que é interrompido por um ou mais átomos de oxigênio, 3- (alquila Ci-C8)-3-azapentano-l,5-diila ou 4-(alquila Ci-Cs)-4-azaeptano-l,7- diila.[133] A further embodiment of the invention relates to a compound of formula I

(I) where when n is 1 A is -C (= O) -OR'i, -C (= O) -N (R'2) (R'3) OR -SO2-phenyl; when n is 2 A is -C (= O) -O-Zi-OC (= O) -, -C (= O) -N (R ”I) -Z2-N (R” 2) - C (= OJ- or piperazino-N, N'-biscarbonyl; when n is 3 A it is Cj-C1-2 alkane tri- (oxycarbonyl), 3-ethyl-3-azapentane- 1,5,2'-tri- (oxycarbonyl), 1 , 4,7-triazaeptane-1, 4,7-tricarbonyl, 1,4,8-triazaoctan-1,4,8-tricarbonyl or 1,5,9-triazanonane-1,5,9-tricarbonyl; when n 4 A is C4-C16 alkane tetra- (oxycarbonyl), 1,4,7,10-tetraazadecane-1, 4,7,10-tetracarbonyl, 1,4,8,1 l-tetraazaundecane-1,4,8, 11- tetracarbonyl or 1,5,8,12-tetraazadodecane-1,5,8,12-tetracarbonyl; n is 1, 2, 3 or 4; Ri, R2, R3, R4, R5, RÓ, R7, Rs, R9 and Rio are independently of each other H, C1-Cs alkyl, C4-C8 cycloalkyl, phenyl, C1-C4 alkoxy or halogen; R'i is H, C1-C22 alkyl, C2-C1 alkenyl, Cs-alkynyl C1, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-Cs-C1-C4 cycloalkyl, bicyclic or tricyclic Cs-C2o alkyl, C1-C-C4-C4 alkyl, C2-Ci2 alkyl, which is replaced by one or more groups hydroxyl powders, C4-C12 alkyl, which is interrupted by one or more oxygen atoms, C4-C18 alkyl, which is interrupted by a sulfur atom, 2,2,6,6-tetramethylpiperidine-4-yl, 1- ( C 1 -C 6 alkyl) -2,2,6,6-tetramethylpiperidine-4-yl or 1- (C 1 -C 8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C1-C22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, CIO-CIO aryl, cycloalkyl C4-Cs-C1-C4 alkyl, C1-C4 aryl C1-C4 alkyl, C2-C6 alkyl, which is replaced by a hydroxyl group, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (alkyl C1-Cs) -2,2,6,6-tetramethylpiperidine-4-yl or 1- (C1-C8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 form , together with the hydrogen atom to which they are attached to the 5, 6 or 7-membered saturated heterocycle; R ”i and R” 2 are independently of each other H, C-C22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-C1 cycloalkyl -C4, C6-C14 aryl-C1-C4 alkyl; Zi is C2-C12 alkylene, C4-C8 cycloalkylene, C4-C8-bis- (C1-C4 alkylene) cycloalkane, CÓ-CU bis- (C1-C4 alkylene) arene, C3-C6 alkylene, which is replaced by one or more hydroxyl groups, C4-C12 alkylene, which is interrupted by one or more oxygen atoms, hexahydro-bore [3,2- b] furan-3,6-diyl, C4-C8 alkylene, which is interrupted by an atom of sulfur, 3- (C 1 -C 8 alkyl) -3-azapentane-1,5-diyl, 4- (C 1 -C 8 alkyl) -4-azaeptane-1,7-diyl or 1-ethyl-2,2,6, 6-tetramethylpiperidine-4,2'-diyl and Z2 is C2-C12 alkylene, C4-C8 cycloalkylene, CÓ-CH arylene, C4-C8-bis cycloalkane (C1-C4 alkylene), CÓ-CU bis- (C1 alkylene arylene) -C4), C4-C12 alkylene, which is interrupted by one or more oxygen atoms, 3- (C1 -C8 alkyl) -3-azapentane-1,5-diyl or 4- (C1 -Cs alkyl) -4- azaeptane-1,7-diyl.

[134] A compound of formula I is preferred, where when n is 1 A it is -C (= O) -OR'i OU-C (= O) -N (R'2) (R'3); when n is 2 A is -C (= O) -O-Zi-OC (= O) -, -C (= O) -N (R ”I) -Z2-N (R” 2) - C (= O) - or piperazine-N, N'-biscarbonyl; when n is 3 A it is C3-C12 tri- (oxycarbonyl) alkane; when n is 4 A it is C4-C16 alkane tetra- (oxycarbonyl); n is 1, 2, 3 or 4; Ri, R2, R3, R4, R5, R6, R7, RS, R9 and Rio are independently of each other H, C1 -Cs alkyl, C4-C8 cycloalkyl, phenyl, C1-C4 alkoxy or halogen; R'I is H, C1-C22 alkyl, C2-C18 alkenyl, C3-C12 alkynyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-cycloalkyl C1 -C4, bicyclic or tricyclic C5-C20 alkyl, C6-C14-C1-C4 alkyl, C2-C12 alkyl, which is replaced by one or more hydroxyl groups, C4-C12 alkyl, which is interrupted by one or more carbon atoms oxygen, C4-C18 alkyl, which is interrupted by a sulfur atom, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (C 1 -Cs alkyl) -2,2,6,6- tetramethylpiperidine-4 -yl or 1- (C 1-8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C1-22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, COC-CIO aryl, cycloalkyl C4-C8-C1-C4 alkyl, C6-C14-C1-C4 alkyl, C2-C6 alkyl, which is replaced by a hydroxyl group, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (alkyl C1-Cs) -2,2,6,6-tetramethylpiperidine-4-yl or 1- (C1-C8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 form , together with the hydrogen atom to which they are attached to the 5, 6 or 7-membered saturated heterocycle; R ”i and R” 2 are independently of each other H, C-C22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-Cs-C1 cycloalkyl -C4, C0-CU-aryl-C1-C4 alkyl; Zi is C2-C12 alkylene, C4-C8 cycloalkylene, C4-C8-bis- (C1-C4 alkylene) cycloalkane, CÓ-CU bis- (C1-C4 alkylene) arene, C3-CÔ alkylene, which is replaced by one or more hydroxyl groups, C4-C12 alkylene, which is interrupted by one or more oxygen atoms, hexahydro-bore [3,2- b] furan-3,6-diyl, C4-C8 alkylene, which is interrupted by an atom of sulfur, 3- (C 1 -C 8 alkyl) -3-azapentane-1,5-diyl, 4- (C 1 -C 8 alkyl) -4-azaeptane-1,7-diyl or 1-ethyl-2,2,6, 6-tetramethylpiperidine-4,2'-diyl and Z2 is C2-C12 alkylene, C4-C8 cycloalkylene, CÓ-CU arylene, C4-C8-bis cycloalkane (C1-C4 alkylene), CÔ-CU bis- (Ci alkylene) -C4), Q-C12 alkylene, which is interrupted by one or more oxygen atoms, 3- (C1-C8 alkyl) -3-azapentane-1,5-diyl or 4- (C1-C8 alkyl) -4- azaeptane-1,7-diyl.

(I), em que n é 1; A é -C(=O)-OR’i, -C(=O)-N(R’2)(R’3); RI, R2, R3, R4, Rs, RÓ, R7, Rs, R9 e Rio são independentemente um do outro H, alquila Ci-C8, cicloalquila C4-C8, fenila, alcóxi C1-C4 ou halogênio; R’i é H, alquila C1-C22, alquenila C2-Ci8, alcino-ila C3-C12, cicloalquila C4-C8, que é não substituído ou substituído por um a três alquila Ci-C4, cicloalquila C4-C8-alquila C1-C4, alquila Cs-C2o bicíclica ou tricíclica, arila Có-Cn-alquila C1-C4, alquila C2-Ci2, que é substituído por um ou mais grupos hidroxila, alquila C4-C12, que é interrompido por um ou mais átomos de oxigênio, alquila C4-Ci8, que é interrompido por um átomo de enxofre, 2,2,6,6-tetrametilpiperidino-4-ila, 1-(alquila Ci-Cs)-2,2,6,6- tetrametilpiperidino-4-ila ou 1-(alcóxi Ci-Ci8)-2,2,6,6-tetrametilpiperidino-4- ila; R’2 e R’3 são independentemente um do outro H, alquila Ci- C22, alquenila C2-C18, cicloalquila C4-C8, que é não substituído ou substituído por um a três alquila C1-C4, arila CÓ-CIO, cicloalquila C4-C8-alquila C1-C4, arila C6-Ci4-alquila C1-C4, alquila C2-C8, que é substituído por um grupo hidroxila, 2,2,6,6-tetrametilpiperidino-4-ila, 1-(alquila Ci-Cs)-2,2,6,6- tetrametilpiperidin-4-ila ou 1-(alcóxi Ci-Ci8)-2,2,6,6-tetrametilpiperidino-4- ila ou R’2 e R’3 forma, junto com o átomo de hidrogênio ao qual estes são ligados ao heterociclo saturado de 5, 6 ou 7 membros; que compreende a etapa de reagir um composto da fórmula II

em que Ri, R2, R3, R4, Rs, RÓ, R7, Rs, R9 e Rio tem o mesmo significado como indicado acima; com um composto da fórmula III

em que Re é alquila Ci-Cs; Y é OR’i OUN(R’2)(R’3) e R’i, R’2 e R’3 tem o mesmo significado como indicado acima; na presença de uma base orgânica ou inorgânica e um solvente.[135] A further embodiment of the invention relates to a method of synthesis for a compound of formula I

(I), where n is 1; A is -C (= O) -OR'i, -C (= O) -N (R'2) (R'3); RI, R2, R3, R4, Rs, RÓ, R7, Rs, R9 and Rio are independently of each other H, C1-C8 alkyl, C4-C8 cycloalkyl, phenyl, C1-C4 alkoxy or halogen; R'i is H, C1-C22 alkyl, C2-C18 alkenyl, C3-C12 alkynyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-cycloalkyl C1 -C4, bicyclic or tricyclic Cs-C2 alkyl, C1-C4 aryl C1-C4 alkyl, C2-C12 alkyl, which is replaced by one or more hydroxyl groups, C4-C12 alkyl, which is interrupted by one or more carbon atoms oxygen, C4-C18 alkyl, which is interrupted by a sulfur atom, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (C1-Cs alkyl) -2,2,6,6- tetramethylpiperidine-4 -yl or 1- (C 1-8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C1-22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, COC-CIO aryl, cycloalkyl C4-C8-C1-C4 alkyl, C6-C14-C1-C4 alkyl, C2-C8 alkyl, which is replaced by a hydroxyl group, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (alkyl C1-Cs) -2,2,6,6-tetramethylpiperidin-4-yl or 1- (C1-C8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 form , together with the hydrogen atom to which they are attached to the 5, 6 or 7-membered saturated heterocycle; comprising the step of reacting a compound of formula II

where Ri, R2, R3, R4, Rs, RÓ, R7, Rs, R9 and Rio have the same meaning as indicated above; with a compound of formula III

where Re is C 1 -C 6 alkyl; Y is OR'i OUN (R'2) (R'3) and R'i, R'2 and R'3 have the same meaning as indicated above; in the presence of an organic or inorganic base and a solvent.

[136] Preferably, Re is C1-C4 alkyl, in particular methyl or ethyl.

[137] Preferably, the organic base is sodium methanolate or sodium ethanolate.

[138] Preferably, the solvent is methanol or ethanol, in particular methanol.

[139] Preferably, the temperature during synthesis is in the range of 0 ° C to 240 ° C.

em que n é 2; A é -C(=O)-O-Zi-O-C(=O)-; Ri, R2, R3, R4, Rs, RÓ, R7, Rs, R9 e Rio são independentemente um do outro H, alquila Ci-Cs, cicloalquila C4-C8, fenila, alcóxi C1-C4 ou halogênio e Zi é alquileno C2-C12, cicloalquileno C4-C8, cicloalcano C4-C8- bis-(alquileno C1-C4), areno CÓ-CU bis-(alquileno C1-C4), alquileno C3-C6, que é substituído por um ou mais grupos hidroxila, alquileno C4-C12, que é interrompido por um ou mais átomos de oxigênio, hexaidro-furo[3,2- b]furano-3,6-diila, alquileno C4-C8, que é interrompido por um átomo de enxofre, 3-(alquila Ci-Cs)-3-azapentano-l,5-diila, 4-(alquila CI-C8)-4- azaeptano-1,7-diila ou l-etil-2,2,6,6-tetrametilpiperidino-4,2’-diila; que compreende a etapa de reagir um composto da fórmula Ia

em que Ree é alquila Ci-Cs e Ri, R2, R3, R4, Rs, RÓ, R7, Rs, R9 e Rio tem o mesmo significado como indicado acima; com um composto da fórmula V HO—Z—OH (V) em que Zi tem o significado como indicado acima; na presença de um solvente.[140] A further embodiment of the invention relates to a method of synthesis for a compound of formula I

where n is 2; A is -C (= O) -O-Zi-OC (= O) -; Ri, R2, R3, R4, Rs, RÓ, R7, Rs, R9 and Rio are independently of each other H, C1-Cs alkyl, C4-C8 cycloalkyl, phenyl, C1-C4 alkoxy or halogen and Zi is C2- alkylene C12, C4-C8 cycloalkylene, C4-C8-bis- (C1-C4 alkylene) cycloalkane, CÓ-CU bis- (C1-C4 alkylene) arene, C3-C6 alkylene, which is replaced by one or more hydroxyl, alkylene groups C4-C12, which is interrupted by one or more oxygen atoms, hexahydro-bore [3,2- b] furan-3,6-diyl, C4-C8 alkylene, which is interrupted by a sulfur atom, 3- ( C 1 -C 6 alkyl) -3-azapentan-1,5-diyl, 4- (C 1 -C 8 alkyl) -4-azaeptane-1,7-diyl or 1-ethyl-2,2,6,6-tetramethylpiperidine-4 , 2'-diyl; comprising the step of reacting a compound of formula Ia

where Ree is C1 -Cs alkyl and R1, R2, R3, R4, Rs, RÓ, R7, Rs, R9 and Rio have the same meaning as indicated above; with a compound of the formula V HO — Z — OH (V) where Zi has the meaning as indicated above; in the presence of a solvent.

[141] Preferably, the temperature during synthesis is in the range of 70 ° C to 240 ° C.

[142] Preferably, Re is C1-C4 alkyl, in particular methyl or ethyl.

[143] Preferably, the solvent has a boiling point above the Ree-OH boiling point. Preferably, the solvent is free of a hydroxyl group. For example, the solvent is toluene, xylene or dichlorobenzene.

[144] Preferably, the synthesis is conducted under vacuum.

[145] Preferably, a transesterification catalyst is added.

[146] The following examples further illustrate the invention without being limited to it. Example 1: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid methyl ester (201)

[147] 45 g of benzoin (= 2-hydroxy-1,2-bis-phenyl-ethanone; 212 mmol) and 70 g of dimethyl malonate (530 mmol) are dissolved under reflux in 75 ml. of methanol. 22.9 g of sodium methoxide (424 mmol) is dissolved in 1250 ml of methanol and added. The mixture is stirred at 40 ° and then acidified with aqueous hydrochloric acid diluted to pH 3-4. The precipitate is filtered, washed with water and then with methanol and dried under vacuum. 50.8 g of the compound (201) are obtained (81%); mp 113 - 115 °. Example 2: 4,5-Bis- (4-methoxy-phenyl) -2-oxo-2,5-dihydro-furan-3-carboxylic acid methyl ester (202)

[148] 10 g of anisoin (= 2-hydroxy-1,2-bis- (4-methoxy-phenyl) -ethanone; 36.7 mmol) and 12.13 g of dimethyl malonate (91.8 mmol) are dissolved in 70 ml of methanol under reflux. 1.68 g of sodium (73.4 mmol) is dissolved in 70 ml of methanol and added. The mixture is refluxed for 18 h, then cooled to 25 ° and acidified with dilute aqueous hydrochloric acid. The resulting mixture is extracted with ethyl acetate / toluene. The organic phases are washed with water, dried over magnesium sulfate and evaporated to dryness. Recrystallization from methanol yields 5.61 g of compound (202) (41%); mp 107 - 109 °. Example 3: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid starch (203)

[149] 10 g of benzoin (47 mmol) and 11 g of methyl malonamate (94 mmol) are dissolved in 100 ml of refluxing methanol. 5.07 g of sodium methoxide (94 mmol) is dissolved in 40 ml of methanol and added. The mixture is refluxed for 1h. The resulting suspension is acidified at 25 ° with aqueous hydrochloric acid diluted to pH 3-4 and the precipitate is filtered, dried and recrystallized from toluene. 10.1 g of the compound (203) is obtained (77%); mp 125 - 127 °. Example 4: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid octylamide (204)

[150] 1 g of benzoin (4.7 mmol) and 1.6 g of compound (401) (7 mmol) are dissolved in 5 ml of methanol. 0.63 g of sodium methoxide (9.4 mmol) in 5 ml of methanol is added and the mixture is refluxed for 2 h. The mixture is acidified with aqueous hydrochloric acid diluted to pH 3-4 and extracted twice with ethyl acetate. The organic phases are washed with water, dried over sodium sulfate and evaporated to dryness. 1.25 g of compound (204) is obtained as viscous oil (68%). Example 5: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid cyclohexylamide (205)

[151] In analogy to example 4, benzoin and compound (402) are reacted and compound (205) is obtained (49%); mp 151-153 ° C. Example 6: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid (1,1,3,3-tetramethyl-butyl) -amide (206)

[152] In analogy to example 4, benzoin and compound (403) are reacted and compound (206) is obtained (64%); mp 110-110 ° C. Example 7: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid benzylamide (207)

[153] In analogy to example 4, benzoin and compound (404) are reacted and compound (207) is obtained (54%); mp 173-175 ° C. Example 8: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid (2,2,6,6-tetramethyl-1-propoxy-piperidin-4-yl) -amide (208)

[154] In analogy to example 4, benzoin and compound (405) are reacted and compound (208) is obtained (99%) as a moldable solid; mp 79-85 ° C. Example 9: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid dibutylamide (209)

[155] 7.4 g of benzoin (35 mmol) and 12 g of the compound (406) (52 mmol) are dissolved in 80 ml of refluxing methanol. 3.78 g of sodium methoxide (70 mmol) is dissolved in 40 ml of methanol and added. The reaction mixture is refluxed for 2.5 h. Then, the mixture is acidified with aqueous hydrochloric acid diluted to pH 3-4 and extracted with diethyl ether. The organic phase is separated, washed with water, dried over sodium sulfate and evaporated in vacuo. 13.6 g of the compound (209) is obtained (99%) as a slightly yellow liquid; MS (liquid chromatography / ionization of atmospheric pressure chemistry of mass spectroscopy (positive mode) (= LC / MS APC1 (pos. Mode)): 392 ([MH] +). Example 10: 3- (Morpholino-4- carbonyl) -4,5-diphenyl-5H-furan-2-one (210)

[156] In analogy to example 9, benzoin and compound (407) are reacted and compound (210) is obtained (92%); mp 204-206 ° C. Example 11: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid phenylamide (211)

[157] In analogy to example 9, benzoin and compound (408) are reacted and compound (211) is obtained (58%); mp 148-150 ° C. Example 12: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid ethyl ester (212)

[158] 5 g of compound (201) (17 mmol) is dissolved in 50 ml ethanol and heated to reflux with an oil bath temperature of 100 ° C. A mixture of ethanol and methanol is distilled. Ethanol is replaced regularly under these distillation conditions. After 8 h of distillation, the revolution is complete and the solution is evaporated in vacuo. 4.77 g of compound (212) is obtained (91%) as a viscous oil. Example 13: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid propyl ester (213)

[159] In analogy to example 12, compound (201) and 1-propanol are reacted and compound (213) is obtained (98%) as a liquid. Example 14: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid pentyl ester (214)

[160] In analogy to example 12, compound (201) and 1-pentanol are reacted and compound (214) is obtained (83%) as a liquid. Example 15: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid 1-methoxy-2,2,6,6-tetramethyl-piperidin-4-yl ester (215 )

[161] In analogy to example 12 and with tetralin used as a co-solvent, compound (201) and l-methoxy-2,2,6,6-tetramethyl-piperidin-4-ol are reacted and compound (215) is obtained (37%); mp 143-146 ° C. Example 16: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid cyclohexyl ester (216)

[162] In analogy to example 12, compound (201) and cyclohexanol are reacted and compound (216) is obtained (82%); mp 139-142 ° C. Example 17: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid benzyl ester (217)

[163] In analogy to example 12, compound (201) and benzyl alcohol are reacted and compound (217) is obtained (73%); mp 111-114 ° C. Example 18: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid isopropyl ester (218)

[164] In analogy to example 12, compound (201) and isopropanol are reacted and compound (218) is obtained (85%); mp 120-122 ° C. Example 19: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid tert-butyl ester (219)

[165] In analogy to example 12, compound (201) and 2-methyl-2-propanol are reacted and compound (219) is obtained (75%); mp 109-111 ° C. Example 20: Bis- (2-oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid) cyclohexane-1,4-diyl diester (220)

[166] 50 g of compound (201) (170 mmol) is melted at 140 °. 10 g of cyclohexan-1,4-diol (mixture of eis- and trans-isomer, 87 mmol) is added and followed by the addition of 20 ml of o-dichlorobenzene. The resulting methanol is distilled at an oil bath temperature of 190 °. After 6h the mixture is cooled to room temperature and 50 ml of toluene is added. The precipitate is filtered, washed with toluene, then hexane, and dried in vacuo. 18.61 g of the compound (220) as a mixture of isomers is obtained (33%); mp 237-240 ° C. Example 21: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carboxylic acid (221)

[167] 15 g of compound (219) (44 mmol) is stirred in 100 ml of sulfuric acid (96%) at 25 °. After 1 h, the solution is added dropwise to a mixture of ice water and dichloromethane under stirring. The organic phases are washed with water, then brine, dried over sodium sulfate and evaporated to dryness. Recrystallization from chloroform yields 5.77 g of compound (221) (46%); mp 116-117 °. Example 22: 2-Oxo-4,5-diphenyl-2,5-dihydro-furan-3-carbonitrile (222)

[168] Compound (222) is prepared according to JA McRae and AL Kuehner, Journal of the American Chemical Society, 1930, 52, 3377-3382. Example 23: 4,5-Bis- (4-methoxy-phenyl) -2-oxo-2,5-dihydro-furan-3-carbonitrile (223)

[169] The compound (223) is prepared in analogy to the compound (222). Example 24: 4,5-Diphenyl-5H-furan-2-one (224)

[170] Compound (224) is a known compound.

[171] 10 g of benzoin (47 mmol) and 37.6 g of dimethyl malonate (235 mmol) are heated to 170 ° C for 2 h. After cooling to room temperature, the reaction mass is triturated with hexane, the precipitate is filtered and dried under vacuum. 6.7 g of the compound (224) is obtained (60.5%) as white crystals; mp 147 - 149 ° C. Example 25: 3-Benzenesulfonyl-4,5-diphenyl-5H-furan-2-one (225)

[172] In analogy to example 2, 2.92 g of benzoin (13 mmol) and 5.0 g of phenylsulfonyl acetic acid methyl ester (20 mmol) are reacted. 4.02 g of compound (225) is obtained (76%) as yellow oil; MS (LC / MS APC1 (pos. Mode)): 377 ([MH] +). Example 26: 3,4,5-Triphenyl-5H-furan-2-one (226)

[173] Compound (226) is a known compound.

[174] 40 g of benzoin (= 2-hydroxy-1,2-bis-phenyl-ethanone; 188 mmol) and 84.9 g of methyl-phenyl acetate (565 mmol) are dissolved under reflux in 200 ml of methanol . 30.5 g of sodium methoxide (565 mmol) is dissolved in 100 ml of methanol and added. The mixture is stirred at 65 ° C for 15 h and then acidified with aqueous hydrochloric acid diluted to pH 3-4. The precipitate is filtered, washed with water and then with methanol and dried under vacuum. 44.4 g of compound (226) are obtained, which are recrystallized from ethyl acetate / hexane to obtain 29.9 g (51%) of compound (226) as white crystals; mp 120 - 122 ° C, MS (LC / MS APC1 (pos. mode)): 313 ([MH] +). Example 27: N-Octyl malonamic acid methyl ester (401)

[175] 13.2 g of dimethyl malonate (100 mmol) and 6.45 g of octylamine (50 mmol) are heated to 125 ° C and the resulting methanol is distilled. After 2.5 h at 125 °, the reaction mixture is cooled to room temperature, the by-product (bisamide) is precipitated with methanol and removed by filtration. The filtrate is concentrated in vacuo. 7.41 g of compound (401) is obtained (65%) as a liquid; pure by 1H-NMR. Example 28: N-Cyclohexyl malonamic acid methyl ester (402)

[176] In analogy to example 27, compound (402) is obtained (64%); mp 77-78 ° C. Example 29: N- (1,1,3,3-Tetramethyl-butyl) - malonamic acid methyl ester (403)

[177] In analogy to example 27, compound (403) is obtained (97%); mp 74-75 ° C. Example 30: N-Benzyl malonamic acid methyl ester (404)

[178] In analogy to example 27, compound (404) is obtained (63%); mp 51-54 ° C. Example 31: N- (2,2,6,6-Tetramethyl-1-propoxy-piperidin-4-yl) -malonamic acid methyl ester (405)

[179] In analogy to example 27, compound (405) is obtained (55%) as a moldable / semi-crystalline material. Example 32: N, N-Dibutyl malonamic acid methyl ester (406)

[180] 10 g of malonyl methyl monochloride (= chlorocarbonyl-methyl ester of acetic acid; 73 mmol) and 20.8 g of dibutylamine (161 mmol, in excess) are reacted in diethyl ether at 0 ° C. The compound (406) is obtained (78%) as a yellow, viscous oil. Example 33: 3-Morfolin-4-yl-3-oxo-propionic acid methyl ester (407)

[181] In analogy to example 32, compound (407) is obtained (69.5%) as viscous, orange oil. Example 34: N-Phenyl malonamic acid methyl ester (408)

[182] In analogy to example 32, compound (408) is obtained (89.8%) as white crystals. Example 35: Polyol stabilization

[183] Resistance to polyol oxidation is determined by differential scanning calorimetry (DSC). A sample is heated starting at 50 ° C with a heating rate of 5 ° C / min under oxygen until 200 ° C is reached. The appearance of an exothermic peak indicates the start of a thermo-oxidative reaction. The temperature at the beginning of the exothermic peak is noted. A better stabilized sample is characterized by a higher temperature at the beginning.

[184] 100 parts of Lupranol 2084 (RTM BASF; polyol) are mixed with 0.45 parts of a stabilizing composition, which consists of Irganox 1135 (RTM BASF; 0.32 parts based on 100 parts of polyol), Irganox 5057 (RTM BASF; 0.10 parts based on 100 parts polyol) and a compound of formula I according to the invention (0.03 parts based on 100 parts polyol). In comparative example 35a), no stabilizing composition is added.

[185] Lupranol 2084 (RTM BASF) is a tri-functional polyether polyol, which contains predominantly secondary hydroxyl groups and in which it has a hydroxyl number of 48 mg KOH / g, a water content of less than 0.1% and an acid number less than 0.06 mg KOH / g.

[186] Irganox 1135 (RTM BASF) is a phenolic antioxidant and contains 3- (3,5-di-tert-butyl-4-hydroxy-phenyl) -propionic acid isooctyl ester as described:

a) comparativo b) de acordo com a invenção Exemplo 36: Estabilização de espuma macia de poliéter/poliuretano[187] Irganox 5057 (RTM BASF) is an amine antioxidant and is a technical mixture obtained by the reaction of diphenylamine with diisobutylene, comprising c) diphenylamine; β) 4-tert-butyldiphenylamine; y) compounds of group i) 4-tert-butyl-4'-tert-octyldiphenylamine, ii) 4,4'-di-tert-butyldiphenylamine, iii) 2,4,4'-tris-tert-butyldiphenylamine, ε) compounds of the group δ) compounds of the group i) 4-tert-butyl-4'-tert-octyldiphenylamine, ii) o, o ', m, m', or p, p'-di-tert-octyldiphenylamine, iii) 2 , 4-di-tert-butyl-4'-tert-octyldiphenylamine, ɛ) compounds of group i) 4,4'-di-tert-octyldiphenylamine, ii) 2,4-di-tert-octyl-4'-terc -butyldiphenylamine and where no more than 5% by weight of component (oc), 8 to 15% by weight of component β), 24 to 32% by weight of component y), 23 to 34% by weight of component δ) and 21 to 34% by weight of the component ε) are present.Table 1

a) comparative b) according to the invention Example 36: Stabilization of soft polyether / polyurethane foam

Preparation of soft polyether / polyurethane foam:

[188] 0.71 g of a stabilizing composition (0.45 parts based on 100 parts polyol), consisting of Irganox 1135 (RTM BASF; phenolic antioxidant as described in example 35; 0.32 parts based on 100 parts of polyol), Irganox 5057 (RTM BASF; antioxidant amine as described in example 35; 0.10 parts based on 100 parts of polyol) and a compound of formula I according to the invention (0.03 parts based on 100 parts of polyol), is dissolved in 157.1 g of Lupranol 2084 (RTM BASF; polyol as described in example 35). In the case of comparative examples 36a) and 36f), no stabilizing composition is added. 9.84 g of a solution consisting of 1.88 g of Tegostab BF 2370 (RTM Evonik Industries; surfactant based on polysiloxane), 0.24 g of Tegoamin 33 (RTM Evonik Industries; general purpose catalyst based on triethylene diamine ) and 7.7 g of deionized water are added and the reaction mixture is vigorously stirred for 10 seconds at 2600 rpm. 0.31 g of Kosmos 29 (RTM Evonik Industries; gel forming catalyst based on stannous octoate) is then added and the reaction mixture is again vigorously stirred for 18 seconds at 2600 rpm. 92.19 g of Lupranat T80 (RTM BASF; mixture of toluene-2,4- and toluene-2,6-diisocinate) is then added with vigorous stirring for 5 to 7 seconds at 2600 rpm. The mixture is then poured into a 20 x 20 x 20 cm pie box and an exothermic foaming reaction takes place as indicated by an increase in temperature. The foam blocks are cooled and stored at room temperature for 24 hours.

[189] All prepared foam blocks show the comparable initial white color.

Anti-burn test

[190] Burn resistance is determined by static heat aging, ie static alu-block testing. The foam blocks are cut into thin tubes (2 cm thick, 1.5 cm in diameter). From each foam block, a thin tube is adopted as a foam sample. The foam sample is heated in an aluminum block. The temperature is maintained at 180 ° C for 30 minutes.

As notas de rodapé são listadas na tabela 1.Tabela 3

As notas de rodapé são listadas na tabela 1. Exemplo 37: Estabilização de polipropileno[191] Burn resistance is assessed by measuring the color of the foam sample after aging. The measured color is related in terms of the yellowness index (YI) determined in the foam sample according to the ASTM 1926-70 yellowing test. Low YI values indicate little discoloration and high YI values indicate severe discoloration of the samples. The whiter the foam sample remains, the better the foam sample is stabilized.Table 2

Footnotes are listed in Table 1.Table 3

Footnotes are listed in table 1. Example 37: Polypropylene stabilization

Method 1:

[192] The mini-extruder used, which is commercially available from DSM, capable of a flow of the molten polymer in a circle, ie two screws at a twin screw disposition pressure of the molten polymer to the outlet, which is connected to the zone extruder inlet. The temperature of the steel barrel of the mini-extruder can be regulated and the extruder inlet zone can be purged with a gas, which allows the removal of trapped air that originates from the loading of the polymer sample. In addition, a sensor determines the force, which is exerted by the polymer melted in the barrel during the rotation of two screws. A change in viscosity of the molten polymer leads to a change in strength.

[193] The steel support of the extruder is maintained at a temperature of 280 ° C and the inlet zone is maintained under a nitrogen flow of 20 mL / min. At a screw speed of 50 rpm, 9 g of the mixture, which consists of 8.955 g of a random tube-grade polypropylene copolymer (99.95% of the total mixture) and 0.0045 g of a compound according to the invention (0.05% of the total mixture) are loaded. In the case of comparative example 37a), a compound according to the invention is not added. Said random polypropylene copolymer alone already contains 0.2% tetrakis- [3- (3,5-di-tert-butyl-4-hydroxy-phenyl) -propionyloxymethyl] -methane, 0.2% l , 3,5-tri- (2,6-tert-butyl-4-hydroxybenzyl) -2,4,6-trimethylbenzene, 0.1% tris- (2,4-di-tert-butylphenyl) phosphite and 0 , 05% calcium stearate.

[194] Tetrakis- [3- (3,5-di-tert-butyl-4-hydroxy-phenyl) - propionyloxymethyl] methane is a phenolic antioxidant, which is contained, for example, in Irganox 1010 (RTM BASF), as described:

[195] 1,3,5-Tri- (2,6-tert-butyl-4-hydroxybenzyl) -2,4,6-trimethyl Benzene is a phenolic antioxidant, which is contained, for example, in Irganox 1330 (RTM BASF), as described:

[196] Tris- (2,4-di-tert-butylphenyl) phosphite is a phosphite stabilizer, in which it is contained, for example, in Irgafos 168 (RTM BASF), as described:

[197] After loading, the screw speed is maintained at 100 rpm and the force exerted on the barrel is recorded. The test is conducted for 10 min under nitrogen at a flow rate of 20 mL / min. After a curot period, a prompt decrease in strength is recorded. The decrease in strength is quantified as the slope of the force curve for time, in which the slope is calculated between the time period of 7 and 10 minutes. The curve is rather linear during said period. The decrease in strength over time is adopted as the degree of melting degradation of the polymer sample.

[198] Desired is a minimum of degradation, which is expressed by a lower value by the slope of the curve. No degradation should mean zero slope.

[199] The results are shown in table 4. Method 2: multi-pass extrusion test

[200] 2500 g of the random polypropylene copolymer (as described under method 1 including the mentioned additives) is combined with 1.25 g of a compound according to the invention and compound under nitrogen at 220 ° C with a screw extruder twin. In the case of comparative example 37t), a compound according to the invention is not added. The granules are extruded 5 more times at 280 ° C under air. The melt flow of the granules after the 5th extrusion is measured at 230 ° C with a weight of 5 kg according to ISO 1133: 1997.

[201] A much smaller change in the melting index indicates less degradation. Ideally, there should be no change in the melting flow.

As notas de rodapé são listadas na tabela 1.Tabela 5

As notas de rodapé são listadas na tabela 1.[202] The results are shown in Table 5.Table 4

Footnotes are listed in Table 1.Table 5

Footnotes are listed in Table 1.

Claims (20)

1. Composition, characterized by the fact that it comprises a) an organic material susceptible to thermal degradation or induced by oxidative light and b) a compound of formula I

where when n is 1 A is -C (= O) -OR'i, -C (= O) -N (R'2) (R'3), -CN, phenyl, which is unsubstituted or substituted by one or more C 1 -C 6 alkyl, C 1 -C 4 alkoxy, C 5 -C 7 cycloalkyl or halogen, -H or -SO 2 -phenyl; when n is 2 A is -C (= O) -O-Zi-OC (= O) -, -C (= O) -N (R ”I) -Z2-N (R” 2) - C (= O) - or piperazine-N, N'-biscarbonyl; when n is 3 A it is C3-C1-2 alkane tri- (oxycarbonyl), 3-ethyl-3-azapentan-1, 5,2'-tri- (oxycarbonyl), 1, 4,7-triazaeptane-1, 4,7 -tricarbonyl, 1,4,8-triazaoctane-1,4,8-tricarbonyl or 1,5,9-triazanonane-1,5,9-tricarbonyl; when n is 4 A it is C4-C16 alkane tetra- (oxycarbonyl), 1,4,7,10-tetraazadecane-1,4,7,10-tetracarbonyl, 1,4,8,11 -tetraazaundecane-1,4, 8.11 - tetracarbonyl or 1,5,8,12-tetraazadodecane-1,5,8,12-tetracarbonyl; n is 1, 2, 3 or 4; Ri, R2, R3, R4, R5, RÓ, R7, Rs, Rç and Rio are independently of each other H, C1-Cs alkyl, C4-Cs cycloalkyl, phenyl, C1-C4 alkoxy or halogen; R'i is H, C1-C22 alkyl, C2-C18 alkenyl, C3-C12 alkynyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-C1 cycloalkyl -C4, bicyclic or tricyclic C5-C20 alkyl, C6-C14 alkyl C1-C4 alkyl, C2-C12 alkyl, which is replaced by one or more hydroxyl groups, C4-C12 alkyl, which is interrupted by one or more carbon atoms oxygen, C4-C18 alkyl, which is interrupted by a sulfur atom, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (CI-C8 alkyl) -2,2,6,6- tetramethylpiperidine-4 -yl or 1- (C 1-8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C1-22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, COC-CIO aryl, cycloalkyl C4-C8-C1-C4 alkyl, C6-C14-C1-C4 alkyl, C2-C8 alkyl, which is replaced by a hydroxyl group, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (alkyl CI-C8) -2,2,6,6- tetramethylpiperidine-4-yl or 1- (C1-8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 form , together with the hydrogen atom to which they are attached to the 5, 6 or 7-membered saturated heterocycle; R ”i and R” 2 are independently of each other H, C-C22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-C1 cycloalkyl -C4, C0-CU-aryl-C1-C4 alkyl; Zi is C2-C12 alkylene, C4-C8 cycloalkylene, C4-C8-bis- (C1-C4 alkylene) cycloalkane, CÓ-CU bis- (C1-C4 alkylene) arene, C3-C6 alkylene, which is replaced by one or more hydroxyl groups, C4-C12 alkylene, which is interrupted by one or more oxygen atoms, hexahydro-bore [3,2- b] furan-3,6-diyl, C4-C8 alkylene, which is interrupted by an atom of sulfur, 3- (C 1 -C 8 alkyl) -3-azapentane-1,5-diyl, 4- (C 1 -C 8 alkyl) -4-azaeptane-1,7-diyl or 1-ethyl-2,2,6, 6-tetramethylpiperidine-4,2'-diyl and Z2 is C2-C12 alkylene, C4-C8 cycloalkylene, CÓ-CR arylene, C4-Cs-bis cycloalkane (C1-C4 alkylene), CÓ-CM bis- (C1 alkylene arylene) -C4), C4-C12 alkylene, which is interrupted by one or more oxygen atoms, 3- (C1 -C8 alkyl) -3-azapentane-1,5-diyl or 4- (C1 -Cs alkyl) -4- azaeptane-1,7-diyl. 2. Composition according to claim 1, characterized by the fact that in formula I when n is 1 A it is -C (= O) -OR'i, -C (= O) -N (R'2) (R '3), -CN, phenyl, which is unsubstituted or substituted by one to three C 1 -C 6 alkyl or C 1 -C 4 alkoxy, -H or - SCh-phenyl; when n is 2 A is -C (= O) -O-Zi-OC (= O) -, -C (= O) -N (R ”I) -Z2-N (R” 2) - C (= O) - or piperazine-N, N'-biscarbonyl; when n is 3 A is propane-1,2,3-tri- (oxycarbonyl), 2-methyl-propane-1,2,3-tri- (oxycarbonyl), 2-methyl-butane-1,2, r- tri- (oxycarbonyl), 2,2-dimethyl-butane-1,1 ', 1' '-tri- (oxycarbonyl), 2,2-dimethyl-pentane-1,1', 1 ”- tri- (oxycarbonyl) , 3-ethyl-3-azapentan-1,5,2'-tri- (oxycarbonyl); when n is 4 A it is 2,2-dimethyl-propane-1,3, r, l ”-tetra- (oxycarbonyl); n is 1, 2, 3 or 4; Ri, R2, R3, R4, Rs, RÓ, R7, Rs, R9 and Rio are independently of each other H, C1-Cs alkyl, phenyl or C1-C4 alkoxy with the proviso that at least Ri or R5 is H and at least RÓ OU RIO is H; R'i is H, C1-C22 alkyl, C2-C18 alkenyl, C5-C7 cycloalkyl, which is unsubstituted or substituted by a C1-C4 alkyl, C5-C7 cycloalkyl-C1-C4 alkyl, Có-Cio-alkyl aryl C1-C4, C4-C12 alkyl, which is interrupted by one or more oxygen atoms, 2,2,6,6-tetramethylpiperidino-4-yl, 1- (C1-C6 alkyl) -2,2,6,6 -tetramethylpiperidine-4-yl or 1- (CI-COC alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C1-C22 alkyl, C2-C18 alkenyl, C5-C7 cycloalkyl, which is unsubstituted or replaced by C1-C4 alkyl, Cg-C10 aryl, Cs-cycloalkyl C1-C4-C4-alkyl, aryl C1-C4-C1-C4 alkyl, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (CI-COC alkyl) -2,2,6,6- tetramethylpiperidine- 4-yl or 1- (C 1 -C 6 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 form, together with the hydrogen atom to which they are attached to pyrrolidine, a piperidine or a morpholine; R ”ie R” 2 independently of each other H, C1-C22 alkyl, C2-C18 alkenyl, C5-C7 cycloalkyl, which is unsubstituted or substituted by C1-C4 alkyl, Cs-C7-C1-C4 cycloalkyl, aryl C-C10-C1-C4 alkyl, Zi is C2-C12 alkylene, C5-C7 cycloalkylene, C5-C7-bis- (C1-C4 alkylene) cycloalkane, COC-CIO bis- (C1-C4 alkylene) arylene CS-CÓ, which is replaced by one or more hydroxyl groups, C4-C12 alkylene, which is interrupted by one or more oxygen atoms, C4-C8 alkylene, which is interrupted by a sulfur atom, 3- (C1- alkyl) C4) -3-azapentan-1,5-diyl, 4- (C1-C4 alkyl) -4-azaeptane-1,7-diyl or 1-ethyl-2,2,6,6-tetramethylpiperidine-4,2 ' -diyl and Z2 is C2-C12 alkylene, C5-C7 cycloalkylene, C5-CU arylene, C5-C7-bis cycloalkane (C1-C4 alkylene), Ce-Cio bis- arene (C1-C4 alkylene), C4-C12 alkylene , which is interrupted by one or more oxygen atoms, 3- (C 1 -C 4 alkyl) -3-azapentane-1,5-diyl or 4- (C 1 -C 4 alkyl) -4-azaeptane-1,7-diyl. Composition according to claim 1 or 2, characterized by the fact that in formula I when n is 1 A it is -C (= O) -OR'i, -C (= O) -N (R'2) (R'3), -CN, phenyl, -H or - SCh-phenyl; when n is 2 A is -C (= O) -O-Zi-O-C (= O) -; n is 1 or 2; R1, R2, R4, RS, Ró, R7, RJ and Rio are H; R3 and Rs are independently of each other H or C1-4 alkoxy; R'j is H, C1-C12 alkyl, C5-C7 cycloalkyl, which is unsubstituted, phenyl-C1-C4 alkyl, 1- (C1-C6 alkyl) -2,2,6,6-tetramethylpiperidine-4-yl 1- (C 1 -C 6 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C1-12 alkyl, C5-C7 cycloalkyl, which is unsubstituted, C1-10 aryl, C1-C4 phenyl-alkyl, 1- (C1-6 alkyl) - 2,2,6,6-tetramethylpiperidine-4-yl or 1- (alkoxy CI-CÔ) - 2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 forms, together with the atom of hydrogen to which they are attached to pyrrolidine, a piperidine or a morpholine and Zi is C5-C7 cycloalkylene. Composition according to any one of Claims 1 to 3, characterized in that the organic material is selected from the group consisting of a polymer, a wax, a mineral oil and a fat. Composition according to any one of claims 1 to 4, characterized in that the organic material is a polymer, which is semi-synthetic or synthetic. Composition according to claim 5, characterized in that component a) is a polyolefin, a polyether polyol or a polyurethane. Composition according to any one of claims 1 to 6, characterized by the fact that component b) is contained in an amount of 0.0005% to 10% based on the weight of component a). Composition according to any one of claims 1 to 7, characterized in that it comprises component c) as an additional additive. Composition according to claim 8, characterized in that it comprises component c) an additive selected from the group consisting of a phosphite or phosphonite, an acid decontaminant, a phenolic antioxidant and an amino antioxidant. Composition according to claim 8 or 9, characterized in that the weight ratio of component b) to component c) is from 4: 1 to 1: 20. 11. Composition according to any one of claims 8 to 10, characterized in that component d) comprises an additional second additive selected from the group consisting of a phosphite or phosphonite, an acid decontaminant, a phenolic antioxidant or a amine antioxidant. 12. Process for the protection of an organic material susceptible to thermal degradation or induced by oxidative light, characterized by the fact that it comprises the step of incorporation in or application in an organic material as defined in claim 1, a compound of formula I as defined in claim 1. 13. Compound, characterized by the fact that it is of formula I

wherein when n is 1 A is -C (= O) -OR'i, -C (= O) -N (R'2) (R'3) OR -SO2-phenyl; when n is 2 A is -C (= O) -O-Zi-OC (= O) -, -C (= O) -N (R '' I) -Z2-N (R ”2) - C ( = O) - or piperazine-N, N'-biscarbonyl; when n is 3 A it is C3-C1-2 alkane tri- (oxycarbonyl), 3-ethyl-3-azapentan-1, 5,2'-tri- (oxycarbonyl), 1, 4,7-triazaeptane-1, 4,7 -tricarbonyl, 1,4,8-triazaoctane-1,4,8-tricarbonyl or 1,5,9-triazanonane-1,5,9-tricarbonyl; when n is 4 A it is C4-C16 alkane tetra- (oxycarbonyl), 1,4,7,10- tetraazadecane-1,4,7,10-tetracarbonyl, 1,4,8,1 l-tetraazaundecane-1,4 , 8,11- tetracarbonyl or 1,5,8,12-tetraazadodecane-1,5,8,12-tetracarbonyl; n is 1, 2, 3 or 4; Ri, R2, R3, R4, R5, RÓ, R7, Rs, R9 and Rio are independently of each other H, C1-Cs alkyl, C4-C8 cycloalkyl, phenyl, C1-C4 alkoxy or halogen; R'i is H, C1-C22 alkyl, C2-C1 alkenyl, C3-C2 alkynyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-cycloalkyl C1 -C4, C5-C20 bicyclic or tricyclic alkyl, C1-Cu-C1-C4 alkyl, C2-C12 alkyl, which is replaced by one or more hydroxyl groups, C4-C12 alkyl, which is interrupted by one or more carbon atoms oxygen, C4-C18 alkyl, which is interrupted by a sulfur atom, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (C 1 -Cs alkyl) -2,2,6,6- tetramethylpiperidine-4 -yl or 1- (C1-8 alkoxy) -2,2,6,6-tetramethylpiperidin-4-yl; R'2 and R'3 are independently of each other H, C1-C22 alkyl, C2-C1 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or replaced by one to three C1-C4 alkyl, CIO-CIO aryl, cycloalkyl C4-Cs-C1-C4 alkyl, C6-C14-C1-C4 alkyl, C2-C6 alkyl, which is replaced by a hydroxyl group, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (alkyl CI-C8) -2,2,6,6- tetramethylpiperidine-4-yl or 1- (C1-8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 form , together with the hydrogen atom to which they are attached to the 5, 6 or 7-membered saturated heterocycle; R ”i and R” 2 are independently of each other H, C-C22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-C1 cycloalkyl -C4, C0-CU-aryl-C1-C4 alkyl; Zi is C2-C12 alkylene, C4-C8 cycloalkylene, C4-C8-bis- (C1-C4 alkylene) cycloalkane, CÓ-CU bis- (C1-C4 alkylene) arene, C3-C6 alkylene, which is replaced by one or more hydroxyl groups, C4-C12 alkylene, which is interrupted by one or more oxygen atoms, hexahydro-bore [3,2- b] furan-3,6-diyl, C4-C8 alkylene, which is interrupted by an atom of sulfur, 3- (C 1 -C 8 alkyl) -3-azapentane-1,5-diyl, 4- (C 1 -C 8 alkyl) -4-azaeptane-1,7-diyl or 1-ethyl-2,2,6, 6-tetramethylpiperidine-4,2'-diyl and Z2 is C2-C12 alkylene, C4-C8 cycloalkylene, CÓ-CR arylene, C4-C8-bis- (C1-C4 alkylene) cycloalkane, CÓ-CR bis- (alkylene arylene) C1-C4), C4-C12 alkylene, which is interrupted by one or more oxygen atoms, 3- (C1-C8 alkyl) -3-azapentane-1,5-diyl or 4- (C1-C8 alkyl) -4 -azaeptane-1,7-diyl. 14. Compound, characterized by the fact that it is of formula I as defined in claim 13, in which when n is 1 A it is -C (= O) -OR'i OU-C (= O) -N (R'2 ) (R'3); when n is 2 A is -C (= O) -O-Zi-OC (= O) -, -C (= O) -N (R ”I) -Z2-N (R” 2) - C (= O) - or piperazine-N, N'-biscarbonyl; when n is 3 A it is C3-C12 tri- (oxycarbonyl) alkane; when n is 4 A it is C4-C16 alkane tetra- (oxycarbonyl); n is 1, 2, 3 or 4; Ri, R2, R3, R4, Rs, Re, R7, Rs, R9 and Rio are independently of each other H, C1-Cs alkyl, C4-C8 cycloalkyl, phenyl, C1-C4 alkoxy or halogen; R'I is H, C1-C22 alkyl, C2-C18 alkenyl, C3-C12 alkynyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-C8-cycloalkyl C1 -C4, bicyclic or tricyclic C5-C20 alkyl, C6-C14 alkyl C1-C4 alkyl, C2-C12 alkyl, which is replaced by one or more hydroxyl groups, C4-C12 alkyl, which is interrupted by one or more carbon atoms oxygen, C4-C18 alkyl, which is interrupted by a sulfur atom, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (C 1 -Cs alkyl) -2,2,6,6- tetramethylpiperidin-4 -yl or 1- (C 1-8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl; R'2 and R'3 are independently of each other H, C1- C22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, CÔ-CIO aryl, cycloalkyl C4-Cs-C1-C4 alkyl, C6-C14-C1-C4 alkyl, C2-C6 alkyl, which is replaced by a hydroxyl group, 2,2,6,6-tetramethylpiperidine-4-yl, 1- (alkyl C1-Cs) -2,2,6,6-tetramethylpiperidine-4-yl or 1- (C1-C8 alkoxy) -2,2,6,6-tetramethylpiperidine-4-yl or R'2 and R'3 form , together with the hydrogen atom to which they are attached to the 5, 6 or 7-membered saturated heterocycle; R ”ie R” 2 are independently of each other H, C-C22 alkyl, C2-C18 alkenyl, C4-C8 cycloalkyl, which is unsubstituted or substituted by one to three C1-C4 alkyl, C4-Cs-C1 cycloalkyl -C4, C0-CU-aryl-C1-C4 alkyl; Zi is C2-C12 alkylene, C4-C8 cycloalkylene, C4-C8-bis- (C1-C4 alkylene) cycloalkane, C6-C14 bis- (C1-C4 alkylene) arene, C3-C6 alkylene, which is replaced by one or more hydroxyl groups, C4-C12 alkylene, which is interrupted by one or more oxygen atoms, hexahydro-bore [3,2- b] furan-3,6-diyl, C4-C8 alkylene, which is interrupted by an atom of sulfur, 3- (C 1 -C 8 alkyl) -3-azapentane-1,5-diyl, 4- (C 1 -C 8 alkyl) -4-azaeptane-1,7-diyl or 1-ethyl-2,2,6, 6-tetramethylpiperidine-4,2'-diyl and Z2 is C2-C12 alkylene, C4-C8 cycloalkylene, CÓ-CR arylene, C4-C8-bis- (C1-C4 alkylene) cycloalkane, CÓ-CU bis- (alkylene alkylene) C1-C4), C4-C12 alkylene, which is interrupted by one or more oxygen atoms, 3- (C1-C8 alkyl) -3-azapentane-1,5-diyl or 4- (C1-Cs alkyl) -4 -azaeptane-1,7-diyl. 15. Use of a compound of formula I as defined in claim 1, characterized in that it is to stabilize an organic material susceptible to thermal degradation or induced by oxidative light against degradation by oxidation, heat or light. 16. Additive composition, characterized by the fact that it comprises: b) a compound of formula I as defined in claim 1, and c) an additional additive selected from the group consisting of a phosphite and a phosphite, an acid remover, a phenolic antioxidant or an amine antioxidant. 17. Additive composition according to claim 16, characterized by the fact that the weight ratio of component b) to component c) is 10: 1 to 1: 30. An additive composition according to claim 16 or 17, characterized in that it comprises a component d) a second additional additive. 19. Additive composition according to claim 18, characterized in that the second additional additive is selected from a group consisting of a phosphite or phosphonite, an acid remover, a phenolic antioxidant or an amino antioxidant. 20. Additive composition according to claim 18 or 19, characterized in that the weight ratio of component b) to component c) is from 10: 1 to 30: 1 and the weight ratio of component b) to component d) is 10: 1 to 1: 30.